// =============================================================================
//
// publications/script/bd_index.js
//
// Version: ofdt.2001.11.29
//
// =============================================================================
// Owner:
//
// Observatoire Francais des Drogues et Toxicomanies
// 105, rue La Fayette
// 75 010 PARIS
//
// Contact:
// Bernard Legoueix
// 33+(0)1 53 20 16 16
// beleg@ofdt.fr
//
// =============================================================================
// Creation:
//
// E-PLUME VISION
// 69, rue de Lyon
// 75 012 PARIS
//
// Contact:
// Sylvain Cote
// 33+(0)1 43 40 26 41
// sylvain.cote@e-plumevision.com
//
// =============================================================================

// -----------------------------------------------------------------------------
// bd_rom::sReg
// -------------------------------------
function bd_rom_sReg ( _o_id , key_words , theme , collection ) {
    var sReg = false ;
    var s_reg_obj = new Object ;
    s_reg_obj._o_id = _o_id ;
    s_reg_obj.key_words = key_words ;
    s_reg_obj.theme = theme ;
    s_reg_obj.collection = collection ;







    if (this.query.key_words) {
        if ( typeof(this.query.key_words) == 'string' ) {
            for (kw in key_words) {
                if (key_words[kw] == this.query.key_words) {
                    sReg = true ;
                    break ;
                }
            }
            if (this.query.collection) {
                if (this.query.op_collection == 'ET') {
                    sReg = sReg && (collection == this.query.collection) ;
                }
                else {
                    sReg = sReg || (collection == this.query.collection) ;
                }
            }
        }
        else {
          
            if (this.query.op_key_words == 'ET') {
                sReg = true ;
                for (i in this.query.key_words) {
                    ok = false ;
                    for (j in key_words) {
                        if (key_words[j] == this.query.key_words[i]) { ok = true ; break ; }
                    }
                    if ( ! ok ) { sReg = false ; break ;}
                }
            }
            else {
                ok = false ;
                for (i in this.query.key_words) {
                    for (j in key_words) {
                        if (key_words[j] == this.query.key_words[i]) { ok = true ; break ; }
                    }
                    if ( ok ) {break ;}
                }
                sReg = ok ;
            }

            if (this.query.collection) {
                if (this.query.op_collection == 'ET') {
                    sReg = sReg && (collection == this.query.collection) ;
                }
                else {
                    sReg = sReg || (collection == this.query.collection) ;
                }
            }
        }
    }
    else {
        if (this.query.collection) {
            sReg = (collection == this.query.collection) ;
        }
        else {
            sReg = true ;
        }
    }
    
    if ( sReg == true ) {
        this.s_reg ( s_reg_obj ) ;
    }
}
bd_rom.prototype.sReg = bd_rom_sReg ;
// /bd_rom::sReg
// -------------------------------------

// -----------------------------------------------------------------------------
// bd_rom::dReg
// -------------------------------------
function bd_rom_dReg ( _o_id , url , titre , edition ) {
    var d_reg_obj = new Object ;
    d_reg_obj._o_id = _o_id ;
    d_reg_obj.url = url ;
    d_reg_obj.titre = titre ;
    d_reg_obj.edition = edition ;
    
    ext = url.substring (url.lastIndexOf( '.' ) + 1 ) ;
    d_reg_obj.icon = "img/icon_" + ext + ".gif" ;
    this.d_reg ( d_reg_obj ) ;
}
bd_rom.prototype.dReg = bd_rom_dReg ;
// /bd_rom::dReg
// -------------------------------------
index.sReg("x20060115",["ADOLESCENT","CONSOMMATION","ALCOOL","TABAC","CANNABIS","INITIATION","TYPE D USAGE","USAGE HABITUEL","IVRESSE"," ENQUETE","EPIDEMIOLOGIE ANALYTIQUE","JEUNE","PRODUIT ILLICITE"],"","Tendances");
index.sReg("x20060114",["ADOLESCENT","CONSOMMATION","ALCOOL","TABAC","CANNABIS","INITIATION","TYPE D USAGE","USAGE HABITUEL","IVRESSE"," ENQUETE","EPIDEMIOLOGIE ANALYTIQUE","JEUNE","PRODUIT ILLICITE"],"","Dossier de presse");
index.sReg("x20051222",["ADOLESCENT","CONSOMMATION","ENQUETE","MILIEU SOCIOCULTUREL","SANTE","ANXIETE","PRODUIT ILLICITE","TABAC","ALCOOL","CANNABIS","POLYCONSOMMATION"],"","Rapport d étude");
index.sReg("x20051221",["INJECTION","HEROINE","COCAINE","BUPRENORPHINE","HALLUCINOGENES","SURVEILLANCE EPIDEMIOLOGIQUE","MILIEU FESTIF","MILIEU URBAIN","DROGUES DE SYNTHESE","METHADONE","CODEINE","ECSTASY","AMPHETAMINES","GHB","VOIE D'ADMINISTRATION","TYPE D'USAGE","CONDUITE A RISQUE","DIFFUSION DES PRODUITS","CRACK","LSD","CHAMPIGNONS HALLUCINOGENES","CANNABIS","PSYCHOTROPES"],"","Rapport d étude");
index.sReg("x20051216",["INJECTION","MILIEU URBAIN","MILIEU FESTIF","COCAINE","CRACK","HALLUCINOGENES","SURVEILLANCE EPIDEMIOLOGIQUE","BUPRENORPHINE","HEROINE","ECSTASY","LSD","GHB","METHAMPHETAMINE","EVOLUTION","CONSOMMATION"],"","Tendances");
index.sReg("x20051120",["TRAITEMENT AMBULATOIRE","PRODUIT ILLICITE","EVALUATION","EPIDEMIOLOGIE DESCRIPTIVE","PRISE EN CHARGE"],"","Rapport d étude");
index.sReg("x20051117",["TABAC","VENTE","PRIX","EVOLUTION","COMPARAISON","REGION"],"","Tendances");
index.sReg("x20050919",["MILIEU SCOLAIRE","CONDUITE A RISQUE","RECHERCHE","PREVENTION","EVALUATION","ENQUETE","METHODE"],"","Rapport d étude");
index.sReg("x20050713",["REGION","ADOLESCENT","CONSOMMATION","ENQUETE","ALCOOL","TABAC","CANNABIS","PRODUIT ILLICITE"],"","Communiqué de presse");
index.sReg("x20050611",["JEUNE","CONSOMMATION","ENQUETE","CATEGORIE SOCIO-PROFESSIONNELLE","PREVALENCE","EVOLUTION","ALCOOL","TABAC","MEDICAMENTS","CANNABIS","CHAMPIGNONS HALLUCINOGENES","AMPHETAMINES","LSD","HEROINE","GEOGRAPHIE"],"","Rapport d étude");
index.sReg("x20050610",["PROSTITUTION","PRECARITE","VIOLENCE","GROSSESSE","MILIEU PROFESSIONNEL","CONSOMMATION","FACTEUR DE RISQUE","DELINQUANCE","CRIMINALITE","TABAC","PRISON","TRAFIC INTERNATIONAL","PRODUIT ILLICITE","ALCOOL","FAMILLE","ACCIDENT"],"","Rapport d étude");
index.sReg("x2005061",["JEUNE","CONSOMMATION","CANNABIS","TABAC","ALCOOL","MEDICAMENTS","TYPE D'USAGE","ENQUETE","PREVALENCE","PRODUIT ILLICITE"],"","Tendances");
index.sReg("x20050561",["DROGUES DE SYNTHESE","AMPHETAMINES","SURVEILLANCE EPIDEMIOLOGIQUE","ANALYSE CHIMIQUE","PHARMACOLOGIE"],"","Note d information");
index.sReg("x20050460",["REGION","ADOLESCENT","ENQUETE","CONSOMMATION","ALCOOL","TABAC","CANNABIS","POLYCONSOMMATION","EVOLUTION"],"","Rapport d étude");
index.sReg("x20050418",["ALCOOL","DEPISTAGE","MEDECIN GENERALISTE","EVALUATION","REPRESENTATION SOCIALE","METHODE","INTERVENTION","REGION"],"","Rapport d étude");
index.sReg("x20050363",["PREVALENCE","EPIDEMIOLOGIE DESCRIPTIVE","EVOLUTION","ALCOOL","TABAC","HALLUCINOGENES","MEDICAMENTS","CANNABIS","ECSTASY","AMPHETAMINES","COCAINE","SOLVANTS","LSD","CRACK","HEROINE","POPULATION A RISQUE","PRISE EN CHARGE","EFFET SECONDAIRE","ILS","CONDUITE DE VEHICULE","TRAFIC"],"","Tendances");
index.sReg("x20050359",["ENQUETE","EPIDEMIOLOGIE","EVALUATION","POUVOIRS PUBLICS","PROGRAMME","SURVEILLANCE EPIDEMIOLOGIQUE"],"","Rapport d activité");
index.sReg("x20050351",["COCAINE","INTOXICATION","SURVEILLANCE EPIDEMIOLOGIQUE","TOXICITE","ANALYSE CHIMIQUE","SAISIE"],"","Note d information");
index.sReg("x2005032",["PREVALENCE","EPIDEMIOLOGIE DESCRIPTIVE","EVOLUTION","ALCOOL","TABAC","HALLUCINOGENES","MEDICAMENTS","CANNABIS","ECSTASY","AMPHETAMINES","COCAINE","SOLVANTS","LSD","CRACK","HEROINE","POPULATION A RISQUE","PRISE EN CHARGE","ILS","EXCLUSION","CONDUITE DE VEHICULE","TRAFIC"],"","Tendances");
index.sReg("x20050254",["DROGUES DE SYNTHESE","SURVEILLANCE EPIDEMIOLOGIQUE","MEDICAMENTS","TOXICITE","ANALYSE CHIMIQUE","PHARMACOLOGIE","SAISIE","ANESTHESIQUES"],"","Note d information");
index.sReg("x20050153",["DROGUES DE SYNTHESE","SURVEILLANCE EPIDEMIOLOGIQUE","MEDICAMENTS","TOXICITE","ANALYSE CHIMIQUE","PHARMACOLOGIE","SAISIE"],"","Note d information");
index.sReg("x20050152",["COCAINE","INTOXICATION","SURVEILLANCE EPIDEMIOLOGIQUE","TOXICITE","ANALYSE CHIMIQUE"],"","Note d information");
index.sReg("x20050145",["PRISON","ABUS","PRISE EN CHARGE","LEGISLATION","ENQUETE","EVALUATION"],"","Tendances");
index.sReg("x2005013",["PRISON","ABUS","PRISE EN CHARGE","LEGISLATION","ENQUETE","EVALUATION"],"","Tendances");
index.sReg("x20041257",["ALCOOL","TABAC","CANNABIS","MILIEU SCOLAIRE","ENSEIGNEMENT SECONDAIRE","INITIATION","DIFFUSION DES PRODUITS","ADOLESCENT","ENQUETE"],"","Communiqué de presse");
index.sReg("x20041144",["EVOLUTION","INJECTION","HEROINE","COCAINE","BUPRENORPHINE","HALLUCINOGENES","SURVEILLANCE EPIDEMIOLOGIQUE","MILIEU FESTIF","MILIEU URBAIN"],"","Tendances");
index.sReg("x2004114",["EVOLUTION","INJECTION","HEROINE","COCAINE","BUPRENORPHINE","HALLUCINOGENES","SURVEILLANCE EPIDEMIOLOGIQUE","MILIEU FESTIF","MILIEU URBAIN"],"","Tendances");
index.sReg("x20041050",["DROGUES DE SYNTHESE","SURVEILLANCE EPIDEMIOLOGIQUE","HALLUCINOGENES","TOXICITE","ANALYSE CHIMIQUE","PHARMACOLOGIE","SAISIE"],"","Note d information");
index.sReg("x20041049",["DROGUES DE SYNTHESE","SURVEILLANCE EPIDEMIOLOGIQUE","HALLUCINOGENES","TOXICITE","ANALYSE CHIMIQUE","PHARMACOLOGIE","SAISIE"],"","Note d information");
index.sReg("x20041048",["DROGUES DE SYNTHESE","SURVEILLANCE EPIDEMIOLOGIQUE","MEDICAMENTS","TOXICITE","ANALYSE CHIMIQUE","PHARMACOLOGIE","SAISIE"],"","Note d information");
index.sReg("x20041047",["DROGUES DE SYNTHESE","SURVEILLANCE EPIDEMIOLOGIQUE","ECSTASY","TOXICITE","EFFET SECONDAIRE","ANALYSE CHIMIQUE","PHARMACOLOGIE","SAISIE"],"","Note d information");
index.sReg("x20040946",["DROGUES DE SYNTHESE","SURVEILLANCE EPIDEMIOLOGIQUE","MESCALINE","TOXICITE","ANALYSE CHIMIQUE","PHARMACOLOGIE","SAISIE"],"","Note d information");
index.sReg("x20040943",["CANNABIS","ALCOOL","TABAC","PRODUIT ILLICITE","ADOLESCENT","EVOLUTION","CONSOMMATION","ARGENT"],"","Tendances");
index.sReg("x20040858",["TRAITEMENT AMBULATOIRE","PRODUIT ILLICITE","EVALUATION","EPIDEMIOLOGIE DESCRIPTIVE","PRISE EN CHARGE"],"","Rapport d étude");
index.sReg("x20040855",["DROGUES DE SYNTHESE","SURVEILLANCE EPIDEMIOLOGIQUE","AMPHETAMINES","TOXICITE","ANALYSE CHIMIQUE","PHARMACOLOGIE"],"","Note d information");
index.sReg("x2004055",["MORTALITE","USAGER","EPIDEMIOLOGIE DESCRIPTIVE","EVOLUTION","HEROINE","COCAINE","CRACK","INTERPELLATION","ETUDE RETROSPECTIVE"],"","Tendances");
index.sReg("x2004048",["ENQUETE","EPIDEMIOLOGIE","EVALUATION","POUVOIRS PUBLICS","PROGRAMME","SURVEILLANCE EPIDEMIOLOGIQUE"],"","Rapport d activité");
index.sReg("x20040356",["ALCOOL","TABAC","CANNABIS","ADOLESCENT","CONSOMMATION","MEDICAMENTS","EPIDEMIOLOGIE","COMPARAISON","IVRESSE","ECSTASY"],"","Communiqué de presse");
index.sReg("x2002109",["ENQUETE","EPIDEMIOLOGIE","EVALUATION","POUVOIRS PUBLICS","PROGRAMME","SURVEILLANCE EPIDEMIOLOGIQUE"],"","Rapport d activité");
index.sReg("20041221",["ENQUETE","INCARCERATION; DEPENDANCE; PRODUIT LICITE","PRODUIT ILLICITE","ABUS","PRISE EN CHARGE","PRISON"],"","Rapport d étude");
index.sReg("20041025",["ADOLESCENT","ENQUETE","SANTE","JEUNE","EVOLUTION","PREMIER USAGE","ECHEC SCOLAIRE","CONSOMMATION "],"","Rapport d étude");
index.sReg("20041024",["INJECTION","HEROINE","COCAINE","BUPRENORPHINE","HALLUCINOGENES","SURVEILLANCE EPIDEMIOLOGIQUE","MILIEU FESTIF","MILIEU URBAIN","DROGUES DE SYNTHESE","METHADONE","CODEINE","ECSTASY","AMPHETAMINES","GHB","VOIE D'ADMINISTRATION","TYPE D'USAGE","CONDUITE A RI"],"","Rapport d étude");
index.sReg("20041023",["PROSTITUTION","CONSOMMATION","SEXE MASCULIN","COCAINE","CONDUITE A RISQUE","PSYCHOTROPES","ENQUETE","OPIACES","REPRESENTATION SOCIALE","VIH"],"","Rapport d étude");
index.sReg("20041022",["PROSTITUTION","CONSOMMATION","SEXE FEMININ","PSYCHOTROPES","ALCOOL","CONDUITE A RISQUE","ENQUETE","ENTRETIEN","HEPATITE","REPRESENTATION SOCIALE"],"","Rapport d étude");
index.sReg("20041020",["ALCOOLOGIE","CCAA","DEPENDANCE","ALCOOL","ABUS","DISPOSITIF DE SOIN","EVOLUTION","ALCOOLIQUE"],"","Rapport d étude");
index.sReg("20040819",["DROGUES DE SYNTHESE","SURVEILLANCE EPIDEMIOLOGIQUE","AMPHETAMINES","TOXICITE","ANALYSE CHIMIQUE","PHARMACOLOGIE"],"","Note d information");
index.sReg("20040816",["MEDIA","PRESSE","ADULTE JEUNE","INFORMATION","MUSIQUE","HOMOSEXUEL"],"","Rapport d étude");
index.sReg("20040718",["DROGUES DE SYNTHESE","SURVEILLANCE EPIDEMIOLOGIQUE","ECSTASY","TOXICITE","EFFET SECONDAIRE","ANALYSE CHIMIQUE","PHARMACOLOGIE","SAISIE"],"","Note d information");
index.sReg("20040715",["MORTALITE","COHORTE","ILS","HEROINE","COCAINE","CRACK","CANNABIS","ECSTASY","VIH","OVERDOSE","EPIDEMIOLOGIE DESCRIPTIVE","ETUDE RETROSPECTIVE","COMPARAISON"],"","Rapport d étude");
index.sReg("20040714",["ALCOOL","TABAC","CANNABIS","ADOLESCENT","CONSOMMATION","EVOLUTION","COMPARAISON","REGION","EPIDEMIOLOGIE DESCRIPTIVE"],"","Tendances");
index.sReg("2004066",["EPIDEMIOLOGIE DESCRIPTIVE","EVOLUTION","TRAITEMENT DE MAINTENANCE","SUBSTITUTION","USAGER","BUPRENORPHINE","METHADONE","USAGE DETOURNE","USAGE THERAPEUTIQUE","INJECTION","PRESCRIPTION MEDICALE","POSOLOGIE","MILIEU URBAIN","MEDECIN GENERALISTE"],"","Rapport d étude");
index.sReg("2004065",["COUT SOCIAL","TABAC","ALCOOL","PRODUIT ILLICITE","ECONOMIE","POUVOIRS PUBLICS","FISCALITE","METHODE","MORTALITE"],"","Rapport d étude");
index.sReg("2004064",["KETAMINE","CONSOMMATION","INITIATION","VOIE D'ADMINISTRATION","USAGER","USAGE DETOURNE","TRAJECTOIRE","TEMOIGNAGE","EFFET SECONDAIRE","REPRESENTATION SOCIALE","MILIEU FESTIF","PERCEPTION","DIFFUSION DES PRODUITS","EPIDEMIOLOGIE DESCRIPTIVE"],"","Rapport d étude");
index.sReg("2004063",["BUPRENORPHINE","DEPENDANCE","VOIE D'ADMINISTRATION","INJECTION","INITIATION","USAGE DETOURNE","POLYCONSOMMATION","PRECARITE","TRAJECTOIRE","EFFET SECONDAIRE","PATHOLOGIE ORGANIQUE","ENQUETE","ENTRETIEN"],"","Rapport d étude");
index.sReg("20040613",["DROGUES DE SYNTHESE","SURVEILLANCE EPIDEMIOLOGIQUE","MEDICAMENTS","USAGE DETOURNE","TOXICITE","EFFET SECONDAIRE","PHARMACOLOGIE"],"","Note d information");
index.sReg("2004061",["EPIDEMIOLOGIE DESCRIPTIVE","EVOLUTION","TRAITEMENT DE MAINTENANCE","SUBSTITUTION","USAGER","OPIACES","BUPRENORPHINE","USAGE DETOURNE; USAGE THERAPEUTIQUE","INJECTION"],"","Tendances");
index.sReg("2004052",["MORTALITE","USAGER","EPIDEMIOLOGIE DESCRIPTIVE","EVOLUTION","HEROINE","COCAINE","CRACK","INTERPELLATION","ETUDE RETROSPECTIVE"],"","Tendances");
index.sReg("20040512",["DROGUES DE SYNTHESE","SURVEILLANCE EPIDEMIOLOGIQUE","ECSTASY","TOXICITE","EFFET SECONDAIRE","ANALYSE CHIMIQUE","PHARMACOLOGIE","SAISIE"],"","Note d information");
index.sReg("200404221",["MILIEU SCOLAIRE","ENSEIGNEMENT SECONDAIRE","EVOLUTION","TABAC","ALCOOL","CANNABIS","MEDICAMENTS","PRODUIT ILLICITE","TYPE D'USAGE","CONSOMMATION","ADOLESCENT","EPIDEMIOLOGIE"],"","Dossier de presse");
index.sReg("200404220",["MILIEU SCOLAIRE","EVOLUTION","TABAC","ALCOOL","CANNABIS","CONSOMMATION","ADOLESCENT","EPIDEMIOLOGIE"],"","Communiqué de presse");
index.sReg("200403222",["EVALUATION","LEGISLATION","LOI EVIN","TABAC","MILIEU SCOLAIRE","ADOLESCENT"],"","Communiqué de presse");
index.sReg("200403122",["MILIEU SCOLAIRE","ENSEIGNEMENT SECONDAIRE","EVOLUTION","TABAC","ALCOOL","CANNABIS","MEDICAMENTS","PRODUIT ILLICITE","TYPE D'USAGE","CONSOMMATION","ADOLESCENT","EPIDEMIOLOGIE"],"","Tendances");
index.sReg("200402219",["DROGUES DE SYNTHESE","SURVEILLANCE EPIDEMIOLOGIQUE","AMPHETAMINES","TOXICITE","ANALYSE CHIMIQUE","PHARMACOLOGIE"],"","Note d information");
index.sReg("200402123",["SURVEILLANCE EPIDEMIOLOGIQUE","DROGUES DE SYNTHESE","AGE","EPIDEMIOLOGIE","PRIX","ECSTASY","ANALYSE CHIMIQUE","ADDITIFS"],"","Tendances");
index.sReg("200401224",["EPIDEMIOLOGIE","EVALUATION","POLITIQUE","CANNABIS","COMORBIDITE"],"","Communiqué de presse");
index.sReg("200401223",["EPIDEMIOLOGIE","EVALUATION","POLITIQUE","CANNABIS","COMORBIDITE"],"","Communiqué de presse");
index.sReg("200401218",["DROGUES DE SYNTHESE","SURVEILLANCE EPIDEMIOLOGIQUE","TOXICITE","ANALYSE CHIMIQUE","PHARMACOLOGIE"],"","Note d information");
index.sReg("200312216",["DROGUES DE SYNTHESE","SURVEILLANCE EPIDEMIOLOGIQUE","HALLUCINOGENES","TOXICITE","ANALYSE CHIMIQUE","PHARMACOLOGIE"],"","Note d information");
index.sReg("200312207",["PRISON","MORTALITE","EVALUATION","ENQUETE","OVERDOSE"],"","Rapport d étude");
index.sReg("200312206",["BENZODIAZEPINES","TYPE D'USAGE","DIFFUSION DES PRODUITS","USAGE DETOURNE","ENQUETE"],"","Rapport d étude");
index.sReg("200312205",["MILIEU SCOLAIRE","TABAC","LEGISLATION","LOI EVIN","EVALUATION","ENSEIGNEMENT PRIMAIRE","ENSEIGNEMENT SECONDAIRE","CAMPAGNE DE PREVENTION","ENQUETE","ADOLESCENT"],"","Rapport d étude");
index.sReg("200312196",["ALCOOL","ACCIDENT","CONDUITE DE VEHICULE","EPIDEMIOLOGIE DESCRIPTIVE"],"","Tendances");
index.sReg("200312195",["CSST","PRISE EN CHARGE","EVALUATION","EPIDEMIOLOGIE"],"","Rapport d étude");
index.sReg("200312124",["ALCOOL","ACCIDENT","CONDUITE DE VEHICULE","EPIDEMIOLOGIE DESCRIPTIVE","PREVENTION","DEPISTAGE"],"","Tendances");
index.sReg("200311215",["DROGUES DE SYNTHESE","SURVEILLANCE EPIDEMIOLOGIQUE","EPIDEMIOLOGIE","ANALYSE CHIMIQUE","TOXICITE ","PHARMACOLOGIE","ECSTASY","AMPHETAMINES","CAFEINE","MEDICAMENTS","USAGE DETOURNE","HALLUCINOGENES","USAGER","MILIEU FESTIF"],"","Note d information");
index.sReg("200311208",["SURVEILLANCE EPIDEMIOLOGIQUE","METHODE","INFORMATION","PARTENARIAT"],"","Rapport d étude");
index.sReg("200310199",["MILIEU PROFESSIONNEL","DEPISTAGE","ENQUETE","EPIDEMIOLOGIE","ETIOLOGIE","PRODUIT ILLICITE","MEDICAMENTS","TYPE D'USAGE","CONSOMMATION","MEDECIN GENERALISTE","SANTE PUBLIQUE","ALCOOL"],"","Rapport d étude");
index.sReg("200310174",["ADOLESCENT","EPIDEMIOLOGIE DESCRIPTIVE","ENQUETE","SANTE","ALCOOL","TABAC","PRODUIT ILLICITE","CANNABIS","MEDICAMENTS","POLYCONSOMMATION","EVOLUTION"],"","Dossier de presse");
index.sReg("200310173",["ADOLESCENT","EPIDEMIOLOGIE DESCRIPTIVE","ENQUETE","ALCOOL","TABAC","PRODUIT ILLICITE","CANNABIS","MEDICAMENTS","POLYCONSOMMATION"],"","Communiqué de presse");
index.sReg("2003099",["PROGRAMME","POLITIQUE","EVALUATION","PREVENTION","DEPARTEMENT","COLLECTIVITE LOCALE","POUVOIRS PUBLICS","TRAVAILLEUR SOCIAL","FINANCEMENT","SANTE PUBLIQUE"],"","Rapport d étude");
index.sReg("2003098",["PROGRAMME","POLITIQUE","EVALUATION","FORMATION","TRAVAILLEUR SOCIAL","FINANCEMENT","COLLECTIVITE LOCALE","COLLECTIVITE TERRITORIALE","POUVOIRS PUBLICS","COMPARAISON"],"","Rapport d étude");
index.sReg("2003097",["PROGRAMME","POLITIQUE","EVALUATION","DEPARTEMENT","COLLECTIVITE LOCALE","POUVOIRS PUBLICS","PARTENARIAT","FINANCEMENT","PRISE EN CHARGE","JUSTICE"],"","Rapport d étude");
index.sReg("200309197",["ECSTASY","DROGUES DE SYNTHESE","SURVEILLANCE EPIDEMIOLOGIQUE","ANALYSE CHIMIQUE","MDA","MDEA","POLYCONSOMMATION","PRIX"],"","Tendances");
index.sReg("200309172",["ECSTASY","DROGUES DE SYNTHESE","SURVEILLANCE EPIDEMIOLOGIQUE","ANALYSE CHIMIQUE","MDA","MDEA","POLYCONSOMMATION","PRIX"],"","Tendances");
index.sReg("200309171",["ADOLESCENT","EPIDEMIOLOGIE DESCRIPTIVE","ENQUETE","COHORTE","MILIEU SOCIOCULTUREL","SANTE","SOCIALISATION","STYLE DE VIE","ALCOOL","TABAC","PRODUIT ILLICITE","INITIATION","CANNABIS","MEDICAMENTS","POLYCONSOMMATION","EVOLUTION","ABSTINENCE","VIOLENCE"],"","Rapport d étude");
index.sReg("20030917",["EVALUATION","POLITIQUE","RECHERCHE","SURVEILLANCE EPIDEMIOLOGIQUE","PREVENTION","REDUCTION DES RISQUES","PRISE EN CHARGE","DROIT PENAL","PRISON","REPRESSION","TRAFIC","MILIEU FESTIF"],"","Rapport d étude");
index.sReg("20030911",["PROGRAMME","POLITIQUE","EVALUATION","REDUCTION DES RISQUES","QUARTIER","REPRESENTATION SOCIALE","POUVOIRS PUBLICS","STRUCTURE DE PROXIMITE","PREVENTION DE PROXIMITE","EFFICACITE"],"","Rapport d étude");
index.sReg("20030910",["PROGRAMME","POLITIQUE","EVALUATION","PRISE EN CHARGE","CSST","PARTENARIAT","ADDICTION","ALCOOL","TABAC","PSYCHOTROPES","DISPOSITIF DE SOIN"],"","Rapport d étude");
index.sReg("200307214",["DROGUES DE SYNTHESE","SURVEILLANCE EPIDEMIOLOGIQUE","HALLUCINOGENES","TOXICITE","ANALYSE CHIMIQUE","PHARMACOLOGIE"],"","Note d information");
index.sReg("200307213",["DROGUES DE SYNTHESE","SURVEILLANCE EPIDEMIOLOGIQUE","HALLUCINOGENES","TOXICITE","ANALYSE CHIMIQUE","PHARMACOLOGIE"],"","Note d information");
index.sReg("200307200",["EVOLUTION","DROGUES DE SYNTHESE","SURVEILLANCE EPIDEMIOLOGIQUE","COCAINE","ECSTASY","LSD","CHAMPIGNONS HALLUCINOGENES","HEROINE","BUPRENORPHINE","BENZODIAZEPINES","MILIEU FESTIF"],"","Communiqué de presse");
index.sReg("200307193",["EVOLUTION","DROGUES DE SYNTHESE","SURVEILLANCE EPIDEMIOLOGIQUE","COCAINE","ECSTASY","LSD","CHAMPIGNONS HALLUCINOGENES","HEROINE","BUPRENORPHINE","BENZODIAZEPINES","MILIEU FESTIF","PROSTITUTION","MEDICAMENTS"],"","Tendances");
index.sReg("200307162",["EVOLUTION","DROGUES DE SYNTHESE","SURVEILLANCE EPIDEMIOLOGIQUE","COCAINE","ECSTASY","LSD","CHAMPIGNONS HALLUCINOGENES","HEROINE","BUPRENORPHINE","BENZODIAZEPINES","MILIEU FESTIF","PROSTITUTION","MEDICAMENTS"],"","Tendances");
index.sReg("200307157",["GROSSESSE","NOUVEAU NE","SUBSTITUTION","METHADONE","BUPRENORPHINE","ENQUETE","POLYCONSOMMATION","SYNDROME DE SEVRAGE","RELATION MERE ENFANT","ENFANT D USAGER","TABAC","PRODUIT ILLICITE"],"","Rapport d étude");
index.sReg("200306192",["TYPE D'USAGE","EVOLUTION","PREVALENCE","EPIDEMIOLOGIE DESCRIPTIVE","ALCOOL","TABAC","MEDICAMENTS","CANNABIS","HEROINE","COCAINE","ECSTASY","REPRESENTATION SOCIALE","POLITIQUE"],"","Tendances");
index.sReg("200306161",["SUBSTITUTION","PRODUIT DE SUBSTITUTION","BUPRENORPHINE","METHADONE","TRAITEMENT DE MAINTENANCE","AMM","DISPOSITIF DE SOIN","CSST","MEDECIN GENERALISTE","RESEAU DE SOINS","PRISON","VIH","HEPATITE","OVERDOSE","ILS"],"","Rapport d étude");
index.sReg("200306158",["DROGUES DE SYNTHESE","SURVEILLANCE EPIDEMIOLOGIQUE","MILIEU URBAIN","MILIEU FESTIF","CONSOMMATION","TYPE D'USAGE","HEROINE","CODEINE","METHADONE","MORPHINE","COCAINE","CRACK","ECSTASY","AMPHETAMINES","CHAMPIGNONS HALLUCINOGENES","LSD","KETAMINE","PARTAGE DE SERINGUE","CONDUITE A RISQUE","VIH","HEPATITE","SAISIE","PRIX","BUPRENORPHINE","VOIE D'ADMINISTRATION","MEDICAMENTS","REPRESENTATION SOCIALE","MEDICAMENTS","USAGE DETOURNE","PROTECTION SOCIALE","REDUCTION DES RISQUES"],"","Rapport d étude");
index.sReg("200306154",["TYPE D'USAGE","EVOLUTION","PREVALENCE","EPIDEMIOLOGIE DESCRIPTIVE","ALCOOL","TABAC","MEDICAMENTS","CANNABIS","HEROINE","COCAINE","ECSTASY","REPRESENTATION SOCIALE","POLITIQUE"],"","Tendances");
index.sReg("200305191",["ADOLESCENT","EVOLUTION","CONSOMMATION","ALCOOL","TABAC","MEDICAMENTS","CANNABIS","TYPE D'USAGE","POLYCONSOMMATION","PRODUIT ILLICITE"],"","Tendances");
index.sReg("200305160",["ECSTASY","DROGUES DE SYNTHESE","SURVEILLANCE EPIDEMIOLOGIQUE","POLYCONSOMMATION","TYPE D'USAGE","MESURES QUANTITATIVES","MESURES QUALITATIVES","ANALYSE CHIMIQUE","VOIE D'ADMINISTRATION","AMPHETAMINES","GHB","KETAMINE","MDA","COCAINE","CAFEINE","MDEA","LSD","MEDICAMENTS","OPIUM","METHAMPHETAMINE"],"","Rapport d étude");
index.sReg("200305159",["SURVEILLANCE EPIDEMIOLOGIQUE","DROGUES DE SYNTHESE","PRODUIT ILLICITE","MEDICAMENTS"],"","Rapport d étude");
index.sReg("200305153",["ADOLESCENT","EVOLUTION","CONSOMMATION","ALCOOL","TABAC","MEDICAMENTS","CANNABIS","TYPE D'USAGE","POLYCONSOMMATION","PRODUIT ILLICITE"],"","Tendances");
index.sReg("200304151",["EVALUATION","RESEAU DE SOINS","CSST","INTERVENANT"],"","Rapport d étude");
index.sReg("200304150",["CSST","RESEAU DE SOINS","ALCOOL","ADDICTION","PRODUIT ILLICITE","SOCIOLOGIE","SANTE PUBLIQUE","EVALUATION","PREVENTION","PARTENARIAT","TRAITEMENT","ENQUETE"],"","Rapport d étude");
index.sReg("200304149",["HEROINE","EVOLUTION","TYPE D'USAGE","ENQUETE","VOIE D'ADMINISTRATION","POLYCONSOMMATION","TRAITEMENT DE MAINTENANCE","PAIR","MILIEU FESTIF","MILIEU URBAIN","PRIX","ADDITIFS","REPRESENTATION SOCIALE","TRAJECTOIRE"],"","Rapport d étude");
index.sReg("200302225",["NOMINATION"],"","Communiqué de presse");
index.sReg("200302198",["REPRESENTATION SOCIALE","OPINION PUBLIQUE","ENQUETE","EPIDEMIOLOGIE","PRODUIT ILLICITE","ALCOOL","TABAC"],"","Communiqué de presse");
index.sReg("200302194",["REPRESENTATION SOCIALE","OPINION PUBLIQUE","ENQUETE","EPIDEMIOLOGIE","PRODUIT ILLICITE","ALCOOL","TABAC","EVOLUTION"],"","Dossier de presse");
index.sReg("200302145",["EPIDEMIOLOGIE DESCRIPTIVE","ALCOOL","TABAC","PRODUIT ILLICITE","ENQUETE","ADOLESCENT","CONSOMMATION"],"","Note d information");
index.sReg("200301190",["OPINION PUBLIQUE","EVOLUTION","REPRESENTATION SOCIALE","PSYCHOTROPES","SUBSTITUTION","REDUCTION DES RISQUES"],"","Tendances");
index.sReg("200301152",["OPINION PUBLIQUE","EVOLUTION","REPRESENTATION SOCIALE","PSYCHOTROPES","SUBSTITUTION","REDUCTION DES RISQUES"],"","Tendances");
index.sReg("200301132",["REPRESENTATION SOCIALE","OPINION PUBLIQUE","PRODUIT ILLICITE","TABAC","ALCOOL","POUVOIRS PUBLICS","STIGMATISATION","ENQUETE","TELEPHONE","INFORMATION"],"","Rapport d étude");
index.sReg("2002123189",["MILIEU FESTIF","MUSIQUE","CONSOMMATION","ENQUETE"],"","Tendances");
index.sReg("2002123135",["MILIEU FESTIF","MUSIQUE","CONSOMMATION","ENQUETE"],"","Tendances");
index.sReg("2002122188",["INTERNET","METHODE","LITTERATURE","EVALUATION"],"","Tendances");
index.sReg("2002122134",["INTERNET","METHODE","LITTERATURE","EVALUATION"],"","Tendances");
index.sReg("200212212",["DROGUES DE SYNTHESE","SURVEILLANCE EPIDEMIOLOGIQUE","AMPHETAMINES HALLUCINOGENES","STIMULANTS","TOXICITE","ANALYSE CHIMIQUE","PHARMACOLOGIE"],"","Note d information");
index.sReg("200212136",["MILIEU FESTIF","MUSIQUE","CONSOMMATION","TYPE D'USAGE","INSERTION","CONTROLE SOCIAL","CANNABIS","MILIEU SOCIOCULTUREL","STYLE DE VIE","ALCOOL","ECSTASY","TABAC","BIERE","RECHERCHE DE SENSATION"],"","Rapport d étude");
index.sReg("2002121187",["MILIEU PROFESSIONNEL","REPRESENTATION SOCIALE","ENQUETE","TYPE D'USAGE"],"","Tendances");
index.sReg("2002121133",["MILIEU PROFESSIONNEL","REPRESENTATION SOCIALE","ENQUETE","TYPE D'USAGE"],"","Tendances");
index.sReg("200211211",["DROGUES DE SYNTHESE","SURVEILLANCE EPIDEMIOLOGIQUE","MDEA","TOXICITE","EFFET SECONDAIRE","ANALYSE CHIMIQUE","PHARMACOLOGIE"],"","Note d information");
index.sReg("200210186",["EXCLUSION","PRECARITE","PAUVRETE","EXCLUSION","SANS ABRI","CONSOMMATION"],"","Tendances");
index.sReg("200210129",["EXCLUSION","PRECARITE","PAUVRETE","SANS ABRI","CONSOMMATION"],"","Tendances");
index.sReg("200209121",["DROGUES DE SYNTHESE","SURVEILLANCE EPIDEMIOLOGIQUE","LEGISLATION","MORTALITE","PHARMACOLOGIE"],"","Note d information");
index.sReg("200209120",["DROGUES DE SYNTHESE","SURVEILLANCE EPIDEMIOLOGIQUE","PHARMACOLOGIE","AMPHETAMINES"],"","Note d information");
index.sReg("20020799",["SURVEILLANCE EPIDEMIOLOGIQUE","SUBSTITUTION","MEDICAMENTS","USAGE DETOURNE","HISTOIRE","TRAFIC","BANLIEUE","QUARTIER","PRISE EN CHARGE","REDUCTION DES RISQUES"],"","Rapport d étude");
index.sReg("200207229",["SURVEILLANCE EPIDEMIOLOGIQUE","DIFFUSION DES PRODUITS","PRODUIT ILLICITE","OPIACES","HEROINE","BUPRENORPHINE","METHADONE","STIMULANTS","COCAINE","ECSTASY","HALLUCINOGENES","KETAMINE","PROTOXYDE D'AZOTE","MEDICAMENTS","BENZODIAZEPINES","MILIEU URBAIN","MIL"],"","Dossier de presse");
index.sReg("200207228",["SURVEILLANCE EPIDEMIOLOGIQUE","DIFFUSION DES PRODUITS","COCAINE","KETAMINE","BENZODIAZEPINES","ECSTASY","MILIEU URBAIN","MILIEU FESTIF","USAGER","CONSOMMATION","TYPE D'USAGE"],"","Communiqué de presse");
index.sReg("200207185",["CONSOMMATION","POPULATION GENERALE","PREMIER USAGE","MILIEU URBAIN","EVOLUTION","MILIEU FESTIF","MEDICAMENTS","PRODUIT ILLICITE"],"","Tendances");
index.sReg("200207137",["BLANCHIMENT","ORGANISATION CRIMINELLE","REPRESSION","PRODUCTION","OPIUM"],"","Drogues, trafic international");
index.sReg("200207119",["DROGUES DE SYNTHESE","SURVEILLANCE EPIDEMIOLOGIQUE","EFFET SECONDAIRE","MEDICAMENTS","USAGE DETOURNE","SEVRAGE","TABAC","POLYCONSOMMATION","ANALYSE CHIMIQUE","ECSTASY"],"","Note d information");
index.sReg("200207118",["PLANTE","SURVEILLANCE EPIDEMIOLOGIQUE","DEPISTAGE","PHARMACOLOGIE","EFFET SECONDAIRE","TYPE d'USAGE"],"","Note d information");
index.sReg("200207110",["MILIEU PROFESSIONNEL","CONSOMMATION","CATEGORIE SOCIO-PROFESSIONNELLE","ETIOLOGIE","TYPE D'USAGE","INSERTION","PRODUIT LICITE","PRODUIT ILLICITE","TRAJECTOIRE","POPULATION CACHEE"],"","Rapport d étude");
index.sReg("200207107",["CONSOMMATION","POPULATION GENERALE","PREMIER USAGE","MILIEU URBAIN","EVOLUTION","MILIEU FESTIF","MEDICAMENTS"],"","Tendances");
index.sReg("200206184",["TABAC","ALCOOL","PRODUIT ILLICITE","ADOLESCENT","POLYCONSOMMATION","CANNABIS","EPIDEMIOLOGIE DESCRIPTIVE"],"","Tendances");
index.sReg("200206131",["ADOLESCENT","SANTE","LOISIR","SOCIALISATION","MODELE STATISTIQUE","ENQUETE","QUESTIONNAIRE","PREVALENCE","CONSOMMATION","POLYCONSOMMATION","CANNABIS","ALCOOL","TABAC","PSYCHIATRIE"],"","Rapport d étude");
index.sReg("200206109",["EVOLUTION","METHODE","MILIEU FESTIF","MILIEU URBAIN","TYPE D'USAGE","PATHOLOGIE","PRODUIT ILLICITE","MEDICAMENTS","USAGE DETOURNE","POLYCONSOMMATION"],"","Rapport d étude");
index.sReg("200206108",["SUBSTITUTION","OPIACES","EVOLUTION","EPIDEMIOLOGIE DESCRIPTIVE","PRESCRIPTION MEDICALE","POLYCONSOMMATION"],"","Rapport d étude");
index.sReg("200206106",["SURVEILLANCE EPIDEMIOLOGIQUE","DROGUES DE SYNTHESE","PREVALENCE","PRODUIT ILLICITE","MEDICAMENTS","ANALYSE CHIMIQUE","SUBSTITUTION","PRESSE"],"","Rapport d étude");
index.sReg("200206104",["TABAC","ALCOOL","PRODUIT ILLICITE","ADOLESCENT","POLYCONSOMMATION","CANNABIS","EPIDEMIOLOGIE DESCRIPTIVE"],"","Tendances");
index.sReg("200205232",["CONDUITE DE VEHICULE","ACCIDENT","PSYCHOTROPES","PRODUIT ILLICITE","CANNABIS","FACTEUR DE RISQUE","DEPISTAGE"],"","Communiqué de presse");
index.sReg("200205231",["EVALUATION","LEGISLATION","LOI EVIN","TABAC","MILIEU SCOLAIRE","ADOLESCENT","OPINION PUBLIQUE"],"","Dossier de presse");
index.sReg("200205230",["EVALUATION","LEGISLATION","LOI EVIN","TABAC","MILIEU SCOLAIRE","ADOLESCENT","OPINION PUBLIQUE"],"","Communiqué de presse");
index.sReg("200205210",["DROGUES DE SYNTHESE","SURVEILLANCE EPIDEMIOLOGIQUE","OPIACES","MEDICAMENTS","USAGE DETOURNE","TOXICITE","ANALYSE CHIMIQUE","PHARMACOLOGIE"],"","Note d information");
index.sReg("200205183",["TABAC","LEGISLATION","MILIEU SCOLAIRE","EVALUATION","OPINION PUBLIQUE"],"","Tendances");
index.sReg("200205169",["TABAC","ALCOOL","PRODUIT ILLICITE","EPIDEMIOLOGIE DESCRIPTIVE","CONSOMMATION","ADOLESCENT"],"","Note d information");
index.sReg("200205103",["TABAC","LEGISLATION","MILIEU SCOLAIRE","EVALUATION","OPINION PUBLIQUE"],"","Tendances");
index.sReg("200205101",["TRAFIC INTERNATIONAL","DROGUES DE SYNTHESE"],"","Drogues, trafic international");
index.sReg("20020497",["HEROINE","PREVENTION","REPRESSION","CONTROLE DES STUPEFIANTS","REDUCTION DES RISQUES"],"","Drogues, trafic international");
index.sReg("200204209",["DROGUES DE SYNTHESE","SURVEILLANCE EPIDEMIOLOGIQUE","ANESTHESIQUES","MEDICAMENTS","USAGE DETOURNE","TOXICITE","ANALYSE CHIMIQUE","PHARMACOLOGIE"],"","Note d information");
index.sReg("200204168",["TABAC","ALCOOL","PRODUIT ILLICITE","EPIDEMIOLOGIE DESCRIPTIVE","CONSOMMATION","ADOLESCENT"],"","Note d information");
index.sReg("200204164",["EPIDEMIOLOGIE DESCRIPTIVE","ALCOOL","TABAC","PRODUIT ILLICITE","ENQUETE","ADOLESCENT","CONSOMMATION"],"","Note d information");
index.sReg("200204125",["PRISE EN CHARGE","EVOLUTION","ENQUETE","MEDECIN GENERALISTE"],"","Rapport d étude");
index.sReg("200204105",["MATERIEL D'INJECTION","TRAJECTOIRE","RECHERCHE DE SENSATION","ENTRETIEN","HISTOIRE","CONDUITE A RISQUE","IMAGE DU CORPS","SANTE PUBLIQUE","POLYCONSOMMATION","SUBSTITUTION"],"","Rapport d étude");
index.sReg("20020395",["PRISE EN CHARGE","MEDECIN GENERALISTE","ENQUETE","EVOLUTION"],"","Tendances");
index.sReg("20020394",["OPIUM","CULTURE ILLICITE","TRAFIC","BLANCHIMENT"],"","Drogues, trafic international");
index.sReg("200203182",["PRISE EN CHARGE","MEDECIN GENERALISTE","ENQUETE","EVOLUTION"],"","Tendances");
index.sReg("200203167",["TABAC","ALCOOL","PRODUIT ILLICITE","EPIDEMIOLOGIE DESCRIPTIVE","CONSOMMATION","ADOLESCENT"],"","Note d information");
index.sReg("200203146",["EPIDEMIOLOGIE DESCRIPTIVE","ALCOOL","TABAC","PRODUIT ILLICITE","ENQUETE","ADOLESCENT","CONSOMMATION"],"","Note d information");
index.sReg("20020296",["CANNABIS","PRODUCTION","COUT","CULTURE ALTERNATIVE"],"","Drogues, trafic international");
index.sReg("200202202",["COCA","PRODUCTION","TRAFIC","SAISIE","OPIUM","REPRESSION","POLICE","GUERRE","ORGANISATION CRIMINELLE","ECOLOGIE","DOUANE","CULTURE ALTERNATIVE"],"","Rapport d étude");
index.sReg("200202166",["TABAC","ALCOOL","PRODUIT ILLICITE","EPIDEMIOLOGIE DESCRIPTIVE","CONSOMMATION","VIOLENCE"],"","Note d information");
index.sReg("200202156",["EPIDEMIOLOGIE DESCRIPTIVE","ALCOOL","TABAC","PRODUIT ILLICITE","ENQUETE","ADOLESCENT","CONSOMMATION"],"","Note d information");
index.sReg("200202117",["DROGUES DE SYNTHESE","SURVEILLANCE EPIDEMIOLOGIQUE","ANALYSE CHIMIQUE","PHARMACOLOGIE"],"","Note d information");
index.sReg("200202102",["ALCOOL","TABAC","CANNABIS","MILIEU SCOLAIRE","ENSEIGNEMENT SECONDAIRE","REPRESENTATION SOCIALE","TYPE D'USAGE","POLYCONSOMMATION","FACTEUR DE RISQUE"],"","Rapport d étude");
index.sReg("200202100",["ALCOOL","TABAC","CANNABIS","MILIEU SCOLAIRE","ENSEIGNEMENT SECONDAIRE","INITIATION","DIFFUSION DES PRODUITS","ADOLESCENT","ENQUETE","TRAJECTOIRE"],"","Rapport d étude");
index.sReg("20020192",["EPIDEMIOLOGIE DESCRIPTIVE","LEGISLATION","RESEAU DE SOINS","DEPENDANCE","POLYCONSOMMATION","TABAC","DOPAGE","MEDICAMENTS","PSYCHOTROPES","MORTALITE"],"","indicateurs et tendances");
index.sReg("20020189",["EPIDEMIOLOGIE DESCRIPTIVE","LEGISLATION","RESEAU DE SOINS","DEPENDANCE","PREVALENCE","PSYCHOTROPES","EVOLUTION","MORTALITE","VIH","REPRESENTATION SOCIALE","INTERDIT"],"","Tendances");
index.sReg("20020187",["COCA","COCAINE","PRODUCTION","ECOLOGIE","REPRESSION"],"","Drogues, trafic international");
index.sReg("20020165",["POLITIQUE","REPRESSION","PREVENTION","PRISE EN CHARGE","TRAFIC","MORBIDITE","MORTALITE","GEOGRAPHIE","EVOLUTION","EVALUATION","DISPOSITIF DE SOIN","GEOGRAPHIE","PRODUIT ILLICITE","PRODUIT LICITE","EPIDEMIOLOGIE"],"","Indicateurs et tendances");
index.sReg("20020164",["POLITIQUE","REPRESSION","PREVENTION","PRISE EN CHARGE","TRAFIC","MORBIDITE","MORTALITE","GEOGRAPHIE","EVOLUTION","EVALUATION","DISPOSITIF DE SOIN","GEOGRAPHIE","PRODUIT ILLICITE","PRODUIT LICITE","EPIDEMIOLOGIE"],"","Indicateurs et tendances");
index.sReg("20020163",["POLITIQUE","REPRESSION","PREVENTION","PRISE EN CHARGE","TRAFIC","MORBIDITE","MORTALITE","GEOGRAPHIE","EVOLUTION","EVALUATION","DISPOSITIF DE SOIN","GEOGRAPHIE","PRODUIT ILLICITE","PRODUIT LICITE","EPIDEMIOLOGIE"],"","Indicateurs et tendances");
index.sReg("20020162",["POLITIQUE","REPRESSION","PREVENTION","PRISE EN CHARGE","TRAFIC","MORBIDITE","MORTALITE","GEOGRAPHIE","EVOLUTION","EVALUATION","DISPOSITIF DE SOIN","GEOGRAPHIE","PRODUIT ILLICITE","PRODUIT LICITE","EPIDEMIOLOGIE"],"","Indicateurs et tendances");
index.sReg("20020161",["POLITIQUE","REPRESSION","PREVENTION","PRISE EN CHARGE","TRAFIC","MORBIDITE","MORTALITE","GEOGRAPHIE","EVOLUTION","EVALUATION","DISPOSITIF DE SOIN","GEOGRAPHIE","PRODUIT ILLICITE","PRODUIT LICITE","EPIDEMIOLOGIE"],"","Indicateurs et tendances");
index.sReg("200201234",["EPIDEMIOLOGIE","PRODUIT LICITE","PRODUIT ILLICITE","OPINION PUBLIQUE","POLITIQUE","CONSOMMATION","EVOLUTION","MORTALITE","LEGISLATION"],"","Dossier de presse");
index.sReg("200201233",["EPIDEMIOLOGIE","CANNABIS","ECSTASY","HEROINE","OPINION PUBLIQUE","CONSOMMATION","LEGISLATION"],"","Communiqué de presse");
index.sReg("200201181",["EPIDEMIOLOGIE DESCRIPTIVE","LEGISLATION","RESEAU DE SOINS","DEPENDANCE","PREVALENCE","PSYCHOTROPES","EVOLUTION","MORTALITE","VIH","REPRESENTATION SOCIALE","INTERDIT"],"","Tendances");
index.sReg("200201170",["EPIDEMIOLOGIE DESCRIPTIVE","ALCOOL","TABAC","PRODUIT ILLICITE","ENQUETE","ADOLESCENT","CONSOMMATION"],"","Note d information");
index.sReg("200201165",["ADOLESCENT","EPIDEMIOLOGIE DESCRIPTIVE","POLYCONSOMMATION","TABAC","ALCOOL","PRODUIT ILLICITE"],"","Note d information");
index.sReg("200201155",["EPIDEMIOLOGIE DESCRIPTIVE","ALCOOL","TABAC","PRODUIT ILLICITE","ENQUETE","ADOLESCENT","CONSOMMATION"],"","Note d information");
index.sReg("200201116",["DROGUES DE SYNTHESE","PHARMACOLOGIE","DEPISTAGE","HISTOIRE","EFFET SECONDAIRE","ECSTASY","AMPHETAMINES","MESCALINE","HALLUCINOGENES","TEMOIGNAGE","POLYCONSOMMATION"],"","Veille Internet");
index.sReg("20020",["EPIDEMIOLOGIE DESCRIPTIVE","ALCOOL","TABAC","PRODUIT ILLICITE","ENQUETE","ADOLESCENT","CONSOMMATION"],"","Note d'information");
index.sReg("20011293",["EPIDEMIOLOGIE","USAGE DETOURNE","BUPRENORPHINE","INJECTION","ENQUETE","POLYCONSOMMATION"],"","Rapport d étude");
index.sReg("20011290",["MEDECIN GENERALISTE","PRESCRIPTION MEDICALE","PSYCHOTROPES","EVOLUTION","SUBSTITUTION","EVALUATION","USAGE DETOURNE","POLYCONSOMMATION"],"","Tendances");
index.sReg("20011288",["OPIUM","PRODUCTION","HEROINE","MARCHE DE LA DROGUE"],"","Drogues, trafic international");
index.sReg("200112203",["CANNABIS","PRODUCTION","COUT","CULTURE ILLICITE"],"","Rapport d étude");
index.sReg("200112180",["MEDECIN GENERALISTE","PRESCRIPTION MEDICALE","PSYCHOTROPES","EVOLUTION","SUBSTITUTION","EVALUATION","USAGE DETOURNE","POLYCONSOMMATION"],"","Tendances");
index.sReg("20011191",["DELINQUANCE","PREVALENCE","PREVENTION","RECHERCHE","VIOLENCE","REINSERTION SOCIALE","THEORIE","METHODE","ALCOOL"],"","Tendances");
index.sReg("20011174",["ORGANISATION CRIMINELLE","PRODUCTION","AMPHETAMINES","POLYCONSOMMATION","REPRESSION","LEGISLATION","DISPOSITIF DE SOIN"],"","Drogues, trafic international");
index.sReg("200111179",["DELINQUANCE","PREVALENCE","PREVENTION","RECHERCHE","VIOLENCE","REINSERTION SOCIALE","THEORIE","METHODE","ALCOOL"],"","Tendances");
index.sReg("20011073",["CANNABIS","REPRESSION","MARCHE DE LA DROGUE"],"","Drogues, trafic international");
index.sReg("20010972",["CANNABIS","PLAQUE TOURNANTE","CONSOMMATION","POLITIQUE","TRAFIC INTERNATIONAL"],"","Drogues, trafic international");
index.sReg("200109227",["TABAC","ALCOOL","CANNABIS","ECSTASY","MEDICAMENTS","PRODUIT ILLICITE","ADOLESCENT","CONSOMMATION","EPIDEMIOLOGIE","MILIEU FESTIF"],"","Dossier de presse");
index.sReg("200109226",["TABAC","ALCOOL","CANNABIS","ECSTASY","MEDICAMENTS","PRODUIT ILLICITE","ADOLESCENT","CONSOMMATION","EPIDEMIOLOGIE"],"","Communiqué de presse");
index.sReg("200109178",["ALCOOL","TABAC","MEDICAMENTS","PSYCHOTROPES","PERSONNE AGEE","EPIDEMIOLOGIE DESCRIPTIVE","DEPENDANCE"],"","Tendances");
index.sReg("200109111",["DROGUES DE SYNTHESE","AMPHETAMINES","HISTOIRE","PHARMACOLOGIE","OVERDOSE","TEMOIGNAGE","EFFET SECONDAIRE"],"","Veille Internet");
index.sReg("2001091",["ALCOOL","TABAC","MEDICAMENTS","PSYCHOTROPES","PERSONNE AGEE","EPIDEMIOLOGIE","DEPENDANCE"],"","Tendances");
index.sReg("20010898",["GROSSESSE","RELATION MERE ENFANT","ENQUETE"],"","Rapport d étude");
index.sReg("20010871",["HEROINE","TRAFIC INTERNATIONAL","PLAQUE TOURNANTE","ORGANISATION CRIMINELLE"],"","Drogues, trafic international");
index.sReg("200108112",["BRONCHODILATATEURS","CATHINONE","KHAT","MBDB","PHARMACOLOGIE","VOIE D'ADMINISTRATION","TEMOIGNAGE","HISTOIRE","EFFET SECONDAIRE"],"","Veille Internet");
index.sReg("2001075",["PRIX","EVOLUTION","CONSOMMATION","PRODUIT ILLICITE","DROGUES DE SYNTHESE","SURVEILLANCE EPIDEMIOLOGIQUE","ANALYSE CHIMIQUE","MEDICAMENTS","USAGE DETOURNE","SUBSTITUTION","MILIEU URBAIN","MILIEU FESTIF"],"","Tendances");
index.sReg("2001072",["FAMILLE D'ACCUEIL","EVALUATION","PRISE EN CHARGE","EPIDEMIOLOGIE"],"","Rapport d étude");
index.sReg("200107177",["PRIX","EVOLUTION","CONSOMMATION","PRODUIT ILLICITE","DROGUES DE SYNTHESE","SURVEILLANCE EPIDEMIOLOGIQUE","ANALYSE CHIMIQUE","MEDICAMENTS","USAGE DETOURNE","SUBSTITUTION","MILIEU URBAIN","MILIEU FESTIF"],"","Tendances");
index.sReg("200107130",["ORGANISATION CRIMINELLE","REPRESSION","REDUCTION DES RISQUES","HEROINE","TRAFIC INTERNATIONAL","ECSTASY"],"","Drogues, trafic international");
index.sReg("20010670",["ORGANISATION CRIMINELLE","HEROINE"],"","Drogues, trafic international");
index.sReg("2001064",["TRAFIC","SOCIOLOGIE","REPRESSION","DIFFUSION DES PRODUITS","ORGANISATION CRIMINELLE","MARCHE DE LA DROGUE","TRAFIC INTERNATIONAL","TRAJECTOIRE"],"","Tendances");
index.sReg("2001063",["PRODUIT ILLICITE","DROGUES DE SYNTHESE","MEDICAMENTS","BUPRENORPHINE","METHADONE","CODEINE","MORPHINE","CHAMPIGNONS HALLUCINOGENES","PROTOXYDE D'AZOTE","CATHINONE","MILIEU URBAIN","MILIEU FESTIF","CONSOMMATION","EVOLUTION","HISTOIRE","VOIE D'ADMINISTRATION","USAGE DETOURNE","BANQUE DE DONNEES","POLYCONSOMMATION","SAISIE","PRIX","TRAFIC","TYPE D'USAGE","ANALYSE CHIMIQUE","ADDITIFS","DIFFUSION DES PRODUITS","EPIDEMIOLOGIE","SURVEILLANCE EPIDEMIOLOGIQUE"],"","Rapport d étude");
index.sReg("200106176",["TRAFIC","SOCIOLOGIE","REPRESSION","SANCTION PENALE","DIFFUSION DES PRODUITS","ORGANISATION CRIMINELLE","MARCHE DE LA DROGUE","TRAFIC INTERNATIONAL","TRAJECTOIRE"],"","Tendances");
index.sReg("2001057",["LEGISLATION","ORGANISATION CRIMINELLE","INTERPELLATION","COLLECTIVITE LOCALE","POLICE","TRAFIC","REVENDEUR","MARCHE DE LA DROGUE","DELINQUANCE","MILIEU URBAIN","TRAJECTOIRE","REVENDEUR","SOCIOLOGIE","DIFFUSION DES PRODUITS"],"","Rapport d étude");
index.sReg("20010569",["TRAFIC INTERNATIONAL","REPRESSION","PREVENTION"],"","Drogues, trafic international");
index.sReg("2001056",["CONSOMMATION","MEDICAMENTS","PSYCHOTROPES","REPRESENTATION SOCIALE","ENQUETE","ETUDE LONGITUDINALE","ETUDE TRANSVERSALE","FACTEUR DE RISQUE"],"","Rapport d étude");
index.sReg("20010554",["LEGISLATION","ORGANISATION CRIMINELLE","INTERPELLATION","COLLECTIVITE LOCALE","POLICE","TRAFIC","REVENDEUR","MARCHE DE LA DROGUE","DELINQUANCE","MILIEU URBAIN","TRAJECTOIRE","REVENDEUR","SOCIOLOGIE","DIFFUSION DES PRODUITS"],"","Rapport d étude");
index.sReg("200105113",["DROGUES DE SYNTHESE","HALLUCINOGENES","VOIE D'ADMINISTRATION","EFFET SECONDAIRE","OVERDOSE","PHARMACOLOGIE","POLYCONSOMMATION","TEMOIGNAGE"],"","Veille Internet");
index.sReg("2001049",["SPORT","DEPENDANCE","ALCOOL","TABAC","CANNABIS","EPIDEMIOLOGIE","TYPE D'USAGE"],"","Tendances");
index.sReg("2001048",["JUSTICE","POLICE","ILS","DELINQUANCE","ALCOOL","TRAJECTOIRE","ENQUETE"],"","Rapport d étude");
index.sReg("20010468",["ORGANISATION CRIMINELLE","TRAFIC INTERNATIONAL","PLAQUE TOURNANTE"],"","Drogues, trafic international");
index.sReg("200104175",["SPORT","DEPENDANCE","ALCOOL","TABAC","CANNABIS","EPIDEMIOLOGIE DESCRIPTIVE","TYPE D'USAGE"],"","Tendances");
index.sReg("200104115",["DROGUES DE SYNTHESE","AMPHETAMINES","PHARMACOLOGIE","TEMOIGNAGE","VOIE D'ADMINISTRATION"],"","Veille Internet");
index.sReg("20010411",["EVOLUTION","PRODUIT DE SUBSTITUTION","MEDECIN GENERALISTE","OBSERVANCE DU TRAITEMENT","EPIDEMIOLOGIE","PRESCRIPTION MEDICALE","USAGE DETOURNE","ENQUETE","EVALUATION","PRISE EN CHARGE"],"","Rapport d étude");
index.sReg("20010410",["RESEAU DE SOINS","PRODUIT DE SUBSTITUTION","OBSERVANCE DU TRAITEMENT","EPIDEMIOLOGIE","MEDECIN GENERALISTE","ETUDE PROSPECTIVE","PRISE EN CHARGE","ENQUETE","EVALUATION"],"","Rapport d étude");
index.sReg("20010386",["REDUCTION DES RISQUES","INJECTION","EVALUATION","BANQUE DE DONNEES","ACCES AUX SOINS","PARTAGE DE SERINGUE"],"","Tendances");
index.sReg("20010367",["CONSOMMATION","ORGANISATION CRIMINELLE"],"","Drogues, trafic international");
index.sReg("20010314",["PRISON","EVALUATION","ENQUETE","SUBSTITUTION","EPIDEMIOLOGIE","SANTE"],"","Rapport d étude");
index.sReg("20010312",["REDUCTION DES RISQUES","INJECTION","EVALUATION","BANQUE DE DONNEES","ACCES AUX SOINS","PARTAGE DE SERINGUE"],"","Tendances");
index.sReg("20010266",["TRAFIC INTERNATIONAL","HEROINE","PRODUCTION","CONSOMMATION"],"","Drogues, trafic international");
index.sReg("20010257",["METHODE","MODELE STATISTIQUE","PREVALENCE","OPIACES","COCAINE","METHADONE","BUPRENORPHINE","EPIDEMIOLOGIE"],"","Rapport d étude");
index.sReg("20010256",["REPRESENTATION SOCIALE","ENQUETE","METHODE","CONDUITE A RISQUE","POLYCONSOMMATION","AMPHETAMINES","COCAINE","ANESTHESIQUES","HEROINE","DATURA","PHENCYCLIDINE","DROGUES DE SYNTHESE","COMPORTEMENT","TYPE D'USAGE","ETHNOGRAPHIE","TEMOIGNAGE"],"","Rapport d étude");
index.sReg("20010216",["METHODE","MODELE STATISTIQUE","PREVALENCE","OPIACES","COCAINE","METHADONE","BUPRENORPHINE","EPIDEMIOLOGIE"],"","Rapport d étude");
index.sReg("20010215",["REPRESENTATION SOCIALE","ENQUETE","METHODE","CONDUITE A RISQUE","POLYCONSOMMATION","AMPHETAMINES","COCAINE","ANESTHESIQUES","HEROINE","DATURA","PHENCYCLIDINE","DROGUES DE SYNTHESE","COMPORTEMENT","TYPE D'USAGE","ETHNOGRAPHIE","TEMOIGNAGE"],"","Rapport d étude");
index.sReg("200102114",["DROGUES DE SYNTHESE","ECSTASY","ANTITUSSIFS","PHARMACOLOGIE","HISTOIRE","MORTALITE","EFFET SECONDAIRE","POLYCONSOMMATION","TEMOIGNAGE"],"","Veille Internet");
index.sReg("20010185",["LEGISLATION","POLITIQUE","EVOLUTION","CANNABIS","CONSOMMATION","POSSESSION DE DROGUE"],"","Tendances");
index.sReg("20010143",["LEGISLATION","POLITIQUE","EVOLUTION","CANNABIS","CONSOMMATION","POSSESSION DE DROGUE"],"","Tendances");
index.sReg("20001284",["ENQUETE","ETUDE TRANSVERSALE","EPIDEMIOLOGIE","CONSOMMATION","TABAC","ALCOOL","CANNABIS","POLYCONSOMMATION","ADOLESCENT"],"","Tendances");
index.sReg("20001244",["ENQUETE","ETUDE TRANSVERSALE","EPIDEMIOLOGIE","CONSOMMATION","TABAC","ALCOOL","CANNABIS","POLYCONSOMMATION","ADOLESCENT"],"","Tendances");
index.sReg("20001233",["POLITIQUE","PROGRAMME","POUVOIRS PUBLICS","SANTE PUBLIQUE","LEGISLATION","EPIDEMIOLOGIE","MODELE STATISTIQUE","EVALUATION","CANNABIS","HEROINE","HISTOIRE","EVOLUTION","PRISE EN CHARGE","REDUCTION DES RISQUES","DISTRIBUTION CONTROLEE"],"","Rapport d étude");
index.sReg("20001218",["ENQUETE","COMPORTEMENT","ADOLESCENT","CONSOMMATION","EPIDEMIOLOGIE","POLYCONSOMMATION","TYPE D'USAGE","FACTEUR DE RISQUE","SPORT","RAVE","METHODE","REPRESENTATION SOCIALE","ETUDE TRANSVERSALE","CANNABIS","ALCOOL","TABAC"],"","Rapport d étude");
index.sReg("20001217",["EVALUATION","STRUCTURE DE PROXIMITE","METHADONE","TRAITEMENT DE MAINTENANCE"],"","Rapport d étude");
index.sReg("20001183",["ALCOOL","CONSOMMATION","ABUS","DELINQUANCE","DELIT","CONDUITE DE VEHICULE"],"","Tendances");
index.sReg("20001145",["ALCOOL","CONSOMMATION","ABUS","DELINQUANCE","DELIT","CONDUITE DE VEHICULE"],"","Tendances");
index.sReg("20001038",["EVALUATION","STRUCTURE DE PROXIMITE","PREVENTION","METHODE","COLLECTIVITE LOCALE","POINT ECOUTE","HISTOIRE"],"","Rapport d étude");
index.sReg("20000939",["COUT","ALCOOL","TABAC","ECONOMIE","PRODUIT ILLICITE"],"","Rapport d étude");
index.sReg("20000858",["INJONCTION THERAPEUTIQUE","INTERPELLATION","EVALUATION","EFFICACITE"],"","Rapport d étude");
index.sReg("20000840",["INJONCTION THERAPEUTIQUE","INTERPELLATION","EVALUATION","EFFICACITE"],"","Rapport d étude");
index.sReg("20000682",["REPRESENTATION SOCIALE","OPINION PUBLIQUE","HEROINE","ENQUETE","ETUDE TRANSVERSALE","EPIDEMIOLOGIE","STIGMATISATION"],"","Tendances");
index.sReg("20000646",["REPRESENTATION SOCIALE","OPINION PUBLIQUE","HEROINE","ENQUETE","ETUDE TRANSVERSALE","EPIDEMIOLOGIE","STIGMATISATION"],"","Tendances");
index.sReg("20000459",["ENQUETE","EPIDEMIOLOGIE","EVALUATION","POUVOIRS PUBLICS","PROGRAMME","SURVEILLANCE EPIDEMIOLOGIQUE"],"","Rapport d activité");
index.sReg("20000441",["REPRESENTATION SOCIALE","ENQUETE","OPINION PUBLIQUE","EVOLUTION","STIGMATISATION","PRODUIT ILLICITE","PRODUIT LICITE","METHODE","PSYCHOTROPES","POUVOIRS PUBLICS","SANTE PUBLIQUE"],"","Rapport d étude");
index.sReg("20000381",["ANESTHESIQUES","CRACK","COCAINE","ECSTASY","CONSOMMATION","POLYCONSOMMATION","MORBIDITE","COMPORTEMENT","EVOLUTION","MILIEU URBAIN","RAVE","DROGUES DE SYNTHESE","ANALYSE CHIMIQUE","BANQUE DE DONNEES"],"","Tendances");
index.sReg("20000355",["ANESTHESIQUES","CRACK","AMPHETAMINES","COCAINE","ECSTASY","HEROINE","LSD","PHENCYCLIDINE","BENZODIAZEPINES","BUPRENORPHINE","MORTALITE","MORBIDITE","CONSOMMATION","PRIX","REPRESENTATION SOCIALE","MARCHE DE LA DROGUE","TRAFIC","DROGUES DE SYNTHESE","EPIDEMIOLOGIE"],"","Rapport d étude");
index.sReg("20000347",["ANESTHESIQUES","CRACK","COCAINE","ECSTASY","CONSOMMATION","POLYCONSOMMATION","MORBIDITE","COMPORTEMENT","EVOLUTION","MILIEU URBAIN","RAVE","DROGUES DE SYNTHESE","ANALYSE CHIMIQUE","BANQUE DE DONNEES"],"","Tendances");
index.sReg("20000342",["USAGER","PRODUIT ILLICITE","ENQUETE","POLICE","JUSTICE","ILS","INTERPELLATION","TYPE D'USAGE","USAGE HABITUEL","REVENDEUR","TRAFIC"],"","Rapport d étude");
index.sReg("20000313",["ANESTHESIQUES","CRACK","AMPHETAMINES","COCAINE","ECSTASY","HEROINE","LSD","PHENCYCLIDINE","BENZODIAZEPINES","BUPRENORPHINE","MORTALITE","MORBIDITE","CONSOMMATION","PRIX","REPRESENTATION SOCIALE","MARCHE DE LA DROGUE","TRAFIC","DROGUES DE SYNTHESE","EPIDEMIOLOGIE"],"","Rapport d étude");
index.sReg("20000280",["PRODUIT ILLICITE","CONSOMMATION","ADOLESCENT","MILIEU SCOLAIRE","EPIDEMIOLOGIE","ENQUETE","EVOLUTION","ALCOOL","TABAC"],"","Tendances");
index.sReg("20000248",["PRODUIT ILLICITE","CONSOMMATION","ADOLESCENT","MILIEU SCOLAIRE","EPIDEMIOLOGIE","ENQUETE","EVOLUTION","ALCOOL","TABAC"],"","Tendances");
index.sReg("19991236",["POLITIQUE","REPRESSION","PREVENTION","PRISE EN CHARGE","TRAFIC","MORBIDITE","MORTALITE","GEOGRAPHIE","EVOLUTION","EVALUATION","DISPOSITIF DE SOIN","GEOGRAPHIE","PRODUIT ILLICITE","PRODUIT LICITE","EPIDEMIOLOGIE"],"","indicateurs et tendances");
index.sReg("19991229",["USAGER","REDUCTION DES RISQUES","CONSOMMATION","CONDUITE A RISQUE","EPIDEMIOLOGIE","SEXUALITE","INJECTION","ECHANGE DE SERINGUES","VIH","HEPATITE","MEDICAMENTS","POLYCONSOMMATION"],"","Rapport d étude");
index.sReg("199912279",["INJECTION","HEROINE","COMPORTEMENT","EVOLUTION"],"","Tendances");
index.sReg("199912249",["INJECTION","HEROINE","COMPORTEMENT","EVOLUTION"],"","Tendances");
index.sReg("199912178",["REPRESENTATION SOCIALE","LEGISLATION","REDUCTION DES RISQUES","OPINION PUBLIQUE","ETUDE TRANSVERSALE","EPIDEMIOLOGIE","PRODUIT ILLICITE"],"","Tendances");
index.sReg("199912150",["REPRESENTATION SOCIALE","LEGISLATION","REDUCTION DES RISQUES","OPINION PUBLIQUE","ETUDE TRANSVERSALE","EPIDEMIOLOGIE","PRODUIT ILLICITE"],"","Tendances");
index.sReg("19991177",["DROGUES DE SYNTHESE","EVOLUTION","SAISIE","ACCES AUX SOINS","HISTOIRE","CONSOMMATION"],"","Tendances");
index.sReg("19991151",["DROGUES DE SYNTHESE","EVOLUTION","SAISIE","ACCES AUX SOINS","HISTOIRE","CONSOMMATION"],"","Tendances");
index.sReg("19991132",["ALCOOL","CANNABIS","ECSTASY","CONSOMMATION","ADOLESCENT","ENQUETE","RAVE","CULTUREL"],"","Rapport d étude");
index.sReg("19991031",["PRODUIT ILLICITE","LSD","ECSTASY","USAGE HABITUEL","RAVE","CONSOMMATION","DROGUES DE SYNTHESE","REPRESSION","TRAFIC","POLITIQUE"],"","Rapport d étude");
index.sReg("19991030",["ECSTASY","AMPHETAMINES","CONSOMMATION","INITIATION","POLYCONSOMMATION","EFFET SECONDAIRE","PREVENTION","TRAFIC","CULTUREL","ETHNOGRAPHIE"],"","Rapport d étude");
index.sReg("19990976",["EPIDEMIOLOGIE","ENQUETE","CONSOMMATION","MORTALITE","PRISE EN CHARGE","SUBSTITUTION","REPRESSION","INTERPELLATION","INJONCTION THERAPEUTIQUE","CONDAMNATION"],"","Tendances");
index.sReg("19990920",["EPIDEMIOLOGIE","ENQUETE","CONSOMMATION","MORTALITE","PRISE EN CHARGE","SUBSTITUTION","REPRESSION","INTERPELLATION","INJONCTION THERAPEUTIQUE","CONDAMNATION"],"","Tendances");
index.sReg("19990519",["REPRESENTATION SOCIALE","ENQUETE","OPINION PUBLIQUE","PREVENTION","ETUDE RETROSPECTIVE"],"","Tendances");
index.sReg("19990460",["ENQUETE","EPIDEMIOLOGIE","EVALUATION","POUVOIRS PUBLICS","PROGRAMME","SURVEILLANCE EPIDEMIOLOGIQUE"],"","Rapport d activité");
index.sReg("19990437",["ENQUETE","EPIDEMIOLOGIE","ADOLESCENT","COMPARAISON","MILIEU SCOLAIRE","VIOLENCE","CONDUITE A RISQUE","PSYCHOTROPES","CANNABIS","ALCOOL","TABAC","MEDICAMENTS","POLYCONSOMMATION","REPRESENTATION SOCIALE","PREVENTION","CONSOMMATION","OPINION PUBLIQUE"],"","Rapport d étude");
index.sReg("19990427",["ENQUETE","COMPARAISON","MILIEU SCOLAIRE","EPIDEMIOLOGIE","REPRESENTATION SOCIALE","CONDUITE A RISQUE","CONSOMMATION","PSYCHOTROPES","ADOLESCENT"],"","Rapport d étude");
index.sReg("19990426",["ENQUETE","METHODE","EPIDEMIOLOGIE","ADOLESCENT","MILIEU SCOLAIRE","FACTEUR DE RISQUE","SUICIDE","VIOLENCE","LOISIR","CONSOMMATION","PSYCHOTROPES","MEDICAMENTS","TABAC","ALCOOL","CANNABIS","PERSONNALITE","FAMILLE","EVOLUTION","COMPARAISON","REPRESENTATION SOCIALE","TEMOIGNAGE"],"","Rapport d étude");
index.sReg("19990325",["HEROINE","COCAINE","TRAFIC","ADOLESCENT","ETHNIE","FAMILLE"],"","Rapport d étude");
index.sReg("19990124",["MILIEU SCOLAIRE","EVALUATION","PROGRAMME","METHODE","EPIDEMIOLOGIE","OPINION PUBLIQUE","PREVENTION","TYPE D'USAGE"],"","Rapport d étude");
index.sReg("199901201",["POLITIQUE","LUTTE","REPRESSION","PREVENTION","PRISE EN CHARGE","TRAFIC","MORBIDITE","MORTALITE","GEOGRAPHIE","EVOLUTION","EVALUATION","DISPOSITIF DE SOIN","GEOGRAPHIE","PRODUIT ILLICITE","PRODUIT LICITE","EPIDEMIOLOGIE DESCRIPTIVE"],"","Indicateurs et tendances");
index.sReg("19981134",["PRISE EN CHARGE","MEDECIN GENERALISTE","SUBSTITUTION","BUPRENORPHINE","ENQUETE","EVOLUTION"],"","Rapport d étude");
index.sReg("199811204",["CONSOMMATION","FACTEUR DE RISQUE","COHORTE","CONDUITE A RISQUE","COMPORTEMENT","DANGER","JEUNE","REPRESENTATION SOCIALE","PREVENTION","LUTTE","OPINION PUBLIQUE","EVOLUTION"],"","Rapport d étude");
index.sReg("19980723",["CANNABIS","COCAINE","CRACK","ECSTASY","HEROINE","USAGER","ILS","INTERPELLATION","DELIT","COMPARAISON","MODELE STATISTIQUE"],"","Rapport d étude");
index.sReg("19980575",["REPRESENTATION SOCIALE","ENQUETE","OPINION PUBLIQUE","PREVENTION","ETUDE RETROSPECTIVE"],"","Tendances");
index.sReg("19980552",["PREVENTION","CONSOMMATION","CONDUITE A RISQUE","PRISE EN CHARGE","PROGRAMME","EDUCATION","POLITIQUE","ENQUETE","EVOLUTION","SOCIOLOGIE"],"","Rapport d étude");
index.sReg("19980522",["POLITIQUE","POUVOIRS PUBLICS","COUT","COLLECTIVITE LOCALE","ECONOMIE","EVALUATION","METHODE"],"","Rapport d étude");
index.sReg("199804128",["ENQUETE","EPIDEMIOLOGIE","EVALUATION","POUVOIRS PUBLICS","PROGRAMME","SURVEILLANCE EPIDEMIOLOGIQUE"],"","Rapport d activité");
index.sReg("19980353",["ENQUETE","METHODE","OPIACES","USAGER","PREVALENCE","EPIDEMIOLOGIE"],"","Rapport d étude");
index.sReg("19980228",["ECSTASY","ENQUETE","CONSOMMATION","MODELE STATISTIQUE","EPIDEMIOLOGIE","PREVENTION"],"","Rapport d étude");
index.sReg("19971135",["ECSTASY","ADOLESCENT","USAGE OCCASIONNEL","USAGE HABITUEL","POLYCONSOMMATION","AMPHETAMINES","EPIDEMIOLOGIE","PHENOMENE DE GROUPE","CULTUREL","CONDUITE A RISQUE","DEPENDANCE","ACCOUTUMANCE","RAVE"],"","Rapport d étude");
index.sReg("19970721",["FAMILLE","PRISE EN CHARGE","ENTRAIDE","THERAPIE FAMILIALE","TEMOIGNAGE","EVOLUTION"],"","Rapport d étude");
index.sReg("199704127",["ENQUETE","EPIDEMIOLOGIE","EVALUATION","POUVOIRS PUBLICS","PROGRAMME","SURVEILLANCE EPIDEMIOLOGIQUE"],"","Rapport d activité");
index.sReg("199604126",["ENQUETE","EPIDEMIOLOGIE","EVALUATION","POUVOIRS PUBLICS","PROGRAMME","SURVEILLANCE EPIDEMIOLOGIQUE"],"","Rapport d activité");
//
index.dReg("x20060115","docs/eftxfbm1.pdf","Les consommations de drogues à la fin de l'adolescence à Paris - Analyse infra-communale de l'enquête ESCAPAD Paris 2004 menée auprès des jeunes de 17 ans. Tendances, 2005, (46), 4 p.","Tendances");
index.dReg("x20060114","docs/epdxjam1.pdf","Dossier de presse Consommations de produits psychoactifs des jeunes parisiens de 17 ans - Restitution des résultats de l’enquête ESCAPAD Paris. St Denis, OFDT, 2006, 7 p.","Dossier de presse");
index.dReg("x20051222","docs/epfxfblc.pdf","Les usages de drogues des adolescents parisiens - Analyse de l'enquête ESCAPAD Paris 2004. St Denis, OFDT, 2005, 200 p.","Rapport d étude");
index.dReg("x20051221","docs/epfxpblc.pdf","Phénomènes émergents liés aux drogues en 2004 - Sixième rapport national du dispositif TREND. St Denis, OFDT, 2005, 176 p.","Rapport d étude");
index.dReg("x20051216","docs/eftxmglc.pdf","Tendances récentes et nouvelles drogues en France - Résultats du sixième rapport national du dispositif TREND : exploitations thématiques 2000-2004 et principales observations 2004. Tendances, 2005, (45), 4 p.","Tendances");
index.dReg("x20051120","docs/epfxcplb.pdf","CSST en ambulatoire - Tableaux statistiques 1998-2003 - Exploitation des rapports d'activité-type des CSST en ambulatoire. St Denis, OFDT, 2005, 46 p.","Rapport d étude");
index.dReg("x20051117","docs/eftxcblb.pdf","Contrebande et ventes de tabac 1999-2004 - Comparaison des évolutions des ventes de cigarettes en France dans les zones frontalières et non frontalières. Tendances, 2005, (44), 4 p.","Tendances");
index.dReg("x20050919","docs/epfxcmk10.pdf","Expérimentation d'un guide de prévention sur les conduites addictives - Applicabilité et utilité d'un guide d'intervention en milieu scolaire. St Denis, OFDT, 2005, 48 p.","Rapport d étude");
index.dReg("x20050713","docs/epcxjal7.pdf","Communiqué de presse Atlas régional des consommations de produits psychoactifs des jeunes Français. Exploitation régionale de l'enquête ESCAPAD 2002/2003. St Denis, OFDT, 2005, 4 p.","Communiqué de presse");
index.dReg("x20050611","docs/epfxfbl6.pdf","Atlas régional des consommations de produits psychoactifs des jeunes Français : exploitation régionale de l'enquête ESCAPAD 2002/2003. St Denis, OFDT, 2005, 224 p.","Rapport d étude");
index.dReg("x20050610","docs/epfxdsk4.pdf","Drogues et dommages sociaux. Revue de littérature internationale. St Denis, OFDT, 2005, 456 p.","Rapport d étude");
index.dReg("x2005061","docs/eftxfbl6.pdf","Consommation de produits psychoactifs des jeunes Français : une approche régionale. Tendances, 2005, (43), 4 p.","Tendances");
index.dReg("x20050561","docs/ir_050519_mdhoet.pdf","Note d'information du 19 mai 2005 : MDHOET - Première identification. St Denis, OFDT, 2005, 2 p.","Note d information");
index.dReg("x20050460","docs/epfxfbk4.pdf","Les consommations de drogues des jeunes Franciliens - Exploitation régionale de l'enquête ESCAPAD 2002/2003. avril 2005. St Denis, OFDT, 2005, 92 p.","Rapport d étude");
index.dReg("x20050418","docs/epfxcdk4.pdf","Repérage Précoce Intervention Brève - Stratégies de promotion du repérage précoce et de l'intervention brève en matière d'alcool auprès des médecins généralistes. St Denis, OFDT, 2005, 220 p.","Rapport d étude");
index.dReg("x20050363","docs/eftxjcl3.pdf","Drogues et dépendances - données essentielles. Tendances, 2005, (42), 4 p.","Tendances");
index.dReg("x20050359","docs/igrxmcl3.pdf","Rapport Annuel 2004. St Denis, OFDT, 2005, 46 p.","Rapport d activité");
index.dReg("x20050351","docs/ir_041215_coca.pdf","Note d'information du 15 décembre 2004 actualisée au 8 mars 2005 : Cocaïne : 24 cas d’intoxications dans 4 régions françaises à la suite d'une consommation de poudre de cocaïne contenant de l'atropine. St Denis, OFDT, 2005, 4 p.","Note d information");
index.dReg("x2005032","docs/eftajcl3.pdf","Drugs and Drug Addictions, Essential Data - Fifth Edition of the Report on Drugs Phenomenon in France, carried out by the OFDT. Tendances, 2005, (42 English), 4 p.","Tendances");
index.dReg("x20050254","docs/ir_050214_tiletamine.pdf","Note d'information du 10 février 2005. Tilétamine - Nouvelle identification. St Denis, OFDT, 2005, 3 p.","Note d information");
index.dReg("x20050153","docs/ir_050131_mcpp.pdf","Note d'information du 31 janvier 2005 actualisée au 3 juin 2005 : m-chlorophénylpipérazine (mCPP) - Nouvelle identification. St Denis, OFDT, 2005, 1 p.","Note d information");
index.dReg("x20050152","docs/ir_050121_leva.pdf","Note d'information du 24 janvier 2005 : Mélange cocaïne et lévamisole. St Denis, OFDT, 2005, 1 p.","Note d information");
index.dReg("x20050145","docs/eftxiol01.pdf","Addictions en milieu carcéral. Enquête sur la prise en charge sanitaire et sociale des personnes détenues présentant une dépendance aux produits licites ou illicites ou ayant une consommation abusive. Tendances, 2005, (41), 4 p.","Tendances");
index.dReg("x2005013","docs/eftaiol1.pdf","Addictions in Prison - A Survey on Socio-Sanitary Care for Addicted Prisoners Using or Overusing Licit or Illicit Substances. Tendances, 2005, (41 English), 4 p.","Tendances");
index.dReg("x20041257","docs/epcxjakc.pdf","Enquête ESPAD 2003 - Résultats européens. St Denis, OFDT, 2004, 4 p.","Communiqué de presse");
index.dReg("x20041144","docs/eftxpbkc.pdf","Phénomènes émergents liés à l'usage de drogues en France en 2003. Tendances, 2004, (40), 4 p.","Tendances");
index.dReg("x2004114","docs/eftapbkc.pdf","Emerging Phenomena related to drug use in France in 2003 - Main Results of the 5th National Report , Tendances, 2005, (40 English), 4 p.","Tendances");
index.dReg("x20041050","docs/ir_030722_5_meo_dmt.pdf","Note d'information du 25 octobre 2004 : 5-MeO-DMT (N,N-dimethyl-5-methoxy-tryptamine) - Nouvelle identification. St Denis, OFDT, 2004, 3 p.","Note d information");
index.dReg("x20041049","docs/ir_031016_5_meo_dipt.pdf","Note d'information du 25 octobre 2004 : 5-MeO-DIPT (N,N-diisopropyl-5-methoxy-tryptamine). St Denis, OFDT, 2004, 3 p.","Note d information");
index.dReg("x20041048","docs/ir_040930_asar.pdf","Note d'information du 25 octobre 2004 : Asarone : Premières identifications. St Denis, OFDT, 2004, 8 p.","Note d information");
index.dReg("x20041047","docs/ir_021129_mdma.pdf","Note d'information du 19 octobre 2004 : Comprimés de MDMA fortement dosés. St Denis, OFDT, 2004, 8 p.","Note d information");
index.dReg("x20040946","docs/ir_031016_2ci.pdf","Note d'information du 22 septembre 2004 : 2 CI (2,5 DIMETHOXY 4-IODOPHENETHYLAMINE) - Nouvelle identification de comprimés. St Denis, OFDT, 2004, 4 p.","Note d information");
index.dReg("x20040943","docs/eftxfbk9.pdf","Cannabis, alcool, tabac et autres drogues à la fin de l'adolescence : usages et évolutions récentes - ESCAPAD 2003. Tendances, 2004, (39), 4 p.","Tendances");
index.dReg("x20040858","docs/epfxcpk8.pdf","CSST en ambulatoire - Tableaux statistiques 1998 / 2002 - Exploitation des rapports d'activité-type des CSST en ambulatoire. St Denis, OFDT, 2004, 32 p.","Rapport d étude");
index.dReg("x20040855","docs/ir_040211_amphe.htm","Note d'information du 12 août 2004. Amphétamine : identification de comprimé fortement dosé. St Denis, OFDT, 2004, 5 p.","Note d information");
index.dReg("x2004055","docs/eftadlk5.pdf","Mortality of individuals arrested for heroin, cocaine or crack use. Tendances, 2005, (36 English), 4 p.","Tendances");
index.dReg("x2004048","docs/igrxmck4.pdf","Bilan d'activité 2003 de l'OFDT. Paris, OFDT, 2004, 41 p.","Rapport d activité");
index.dReg("x20040356","docs/epcxjal3.pdf","Drogues et dépendances - données essentielles. St Denis, OFDT, 2005, 1 p.","Communiqué de presse");
index.dReg("x2002109","docs/igcrjcia.pdf","Bilan d'activité 1999-2002 de l'OFDT. Paris, OFDT, 2002, 39 p.","Rapport d activité");
index.dReg("20041221","docs/epfxiokc.pdf","Addictions en milieu carcéral. Enquête sur la prise en charge sanitaire et sociale des personnes détenues présentant une dépendance aux produits licites ou illicites ou ayant une consommation abusive, 2003. Saint-Denis, OFDT, 2004, 100 p.","Rapport d étude");
index.dReg("20041025","docs/epfxfbka.pdf","Drogues à l'adolescence. Niveaux et contextes d'usage de cannabis, alcool, tabac et autres drogues à 17-18 ans en France - ESCAPAD 2003. Saint-Denis, OFDT, 2004, 251 p.","Rapport d étude");
index.dReg("20041024","docs/epfxpbka.pdf","Phénomènes émergents liés aux drogues en 2003. Cinquième rapport national du dispositif TREND. Saint-Denis, OFDT, 2004, 271 p.","Rapport d étude");
index.dReg("20041023","docs/epfxldka.pdf","La consommation de drogues dans le milieu de la prostitution masculine. Saint-Denis, OFDT, 2004, 149 p.","Rapport d étude");
index.dReg("20041022","docs/epfxscka.pdf","La consommation de drogues dans le milieu de la prostitution féminine. Saint-Denis, OFDT, 2004, 93 p.","Rapport d étude");
index.dReg("20041020","docs/epfxcpkb.pdf","Lutte contre l'alcoolisme. Le dispositif spécialisé en 2002. Saint-Denis, OFDT, 2004, 19 p.","Rapport d étude");
index.dReg("20040819","docs/eisxigk8.pdf","Note d'information du 12 août 2004 : Amphétamine : identification de produits fortement dosés. Paris, OFDT, 2004, 5 p.","Note d information");
index.dReg("20040816","docs/epfxafk8.pdf","Traitement médiatique de l'usage de drogue à travers 7 magazines (Décembre 2000 - Septembre 2003). Rapport sur la veille média du dispositif TREND. Paris, OFDT, 2004, 122 p.","Rapport d étude");
index.dReg("20040718","docs/eisxigk7.pdf","Note d'information du 11 août 2004 : Ecstasy : comprimés et gélules de MDMA fortement dosés. Paris, OFDT, 2004, 7 p.","Note d information");
index.dReg("20040715","docs/epfxdlk7.pdf","Mortalité liée aux drogues illicites. Étude d’une cohorte rétrospective de personnes interpellées pour usage de stupéfiants Paris, OFDT, 2004, 158 p.","Rapport d étude");
index.dReg("20040714","docs/eftxfbk7.pdf","Alcool, tabac, cannabis et autres drogues à 17 ans, en Ile-de-France : exploitation régionale de l'enquête ESCAPAD 2002-2003. Tendances, 2004, (38), 1-4","Tendances");
index.dReg("2004066","docs/epfxack6.pdf","Approche régionale de la substitution aux opiacés 1999-2002 : pratiques et disparités à travers 13 sites français Paris, OFDT, 2004, 120 p.","Rapport d étude");
index.dReg("2004065","docs/epfxpkk6.zip","Coût et bénéfices économiques des drogues. Paris, OFDT, 2004, 125 p.","Rapport d étude");
index.dReg("2004064","docs/epfxcrk6.pdf","Usages détournés de la kétamine en France 2001-2003 : « Ket-riding » ou les nouveaux voyages immobiles. Paris, OFDT, 2004, 156 p.","Rapport d étude");
index.dReg("2004063","docs/epfxsek6.pdf","Usages non substitutifs de la buprénorphine haut dosage : investigation menée en France en 2002-2003. Paris, OFDT, 2004, 118 p.","Rapport d étude");
index.dReg("20040613","docs/eisxigk6.pdf","Note d'information du 2 juin 2004 : Médicaments ou ecstasy ? Comprimés collectés dans le cadre de SINTES jusqu'à la fin du 1er trimestre 2004. Paris, OFDT, 2004, 14 p.","Note d information");
index.dReg("2004061","docs/eftxack6.pdf","Les traitements de substitution en France : résultats récents 2004. Tendances, 2004, (37), 1-8","Tendances");
index.dReg("2004052","docs/eftxdlk5.pdf","Mortalité des personnes interpellées pour usage d'héroïne, de cocaïne ou de crack. Tendances, 2004, (36), 1-4","Tendances");
index.dReg("20040512","docs/eisxigk5.pdf","Note d'information du 28 mai 2004 (mise à jour de la note du 17/12/02) : Ecstasy : comprimés et gélules de MDMA fortement dosés. Paris, OFDT, 2004, 7 p.","Note d information");
index.dReg("200404221","docs/epdxjak4.pdf","Premiers résultats de l'enquête ESPAD 2003 en France. Consommation de substances psychoactives des élèves de 12 à 18 ans : évolutions entre 1993 et 2003. Paris, OFDT, 2004, 9 p.","Dossier de presse");
index.dReg("200404220","docs/epcxjak4.pdf","Consommation de substances psychoactives des élèves de 12 à 18 ans : évolutions entre 1993 et 2003. Paris, OFDT, 2004, 2 p.","Communiqué de presse");
index.dReg("200403222","docs/epcxjak3.pdf","Résultats définitifs de la première évaluation de la loi Evin en milieu scolaire. Paris, OFDT, 2004, 2 p.","Communiqué de presse");
index.dReg("200403122","docs/eftxmck3.pdf","Les substances psychoactives chez les collégiens et lycéens : consommations en 2003 et évolutions depuis dix ans. Tendances, 2004, (35), 1-6","Tendances");
index.dReg("200402219","docs/eisxigk2.pdf","Note d'information du 11 février 2004 : Amphétamine, identification de comprimé fortement dosé. Paris, OFDT, 2004, 4 p.","Note d information");
index.dReg("200402123","docs/eftxigk2.pdf","Informations récentes sur les produits de synthèse circulant en France. Les données du dispositif socio sanitaire de SINTES de juillet 2002 à septembre 2003. Tendances, 2004, (34), 1-4","Tendances");
index.dReg("200401224","docs/epcajak1.pdf","2003 French national report on drug situation. Paris, OFDT, 2004, 1 p.","Communiqué de presse");
index.dReg("200401223","docs/epcxjak1.pdf","Mise à disposition du rapport national 2003 produit pour l'Observatoire europeen des drogues et des toxicomanies. Paris, OFDT, 2004, 1 p.","Communiqué de presse");
index.dReg("200401218","docs/eisxigk1.pdf","Note d'information du 30 janvier 2004 (mise à jour de la note du 16/10/03) : Première identification de 2 CI (2,5 dimethoxy 4-iodophenethylamine). Paris, OFDT, 2004, 3 p.","Note d information");
index.dReg("200312216","docs/eisxigjc.pdf","Note d'information du 3 décembre 2003 (mise à jour de la note du 16/10/03) : Première identification de 5-MeO-DIPT (N,N-diisopropyl-5-methoxy-tryptamine). Paris, OFDT, 2003, 3 p.","Note d information");
index.dReg("200312207","docs/epfxjpjc.pdf","Fresnes - Mortalité des sortants : Etude rétrospective de la mortalité des sortants de la maison d’arrêt de Fresnes. Second volet de l’évaluation des unités pour sortants (UPS). Paris, OFDT, 2003, 60 p.","Rapport d étude");
index.dReg("200312206","docs/epfxcrjc.pdf","Consommation de Rohypnol® hors protocole médical depuis février 2001. Zoom sur les conséquences de l'arrêté relatif à la restriction de mise sur le marché du flunitrazepam sur la vie quotidienne de ses consommateurs. Paris, OFDT, 2003, 57 p.","Rapport d étude");
index.dReg("200312205","docs/epfxskjc.pdf","Le tabac en milieu scolaire. Résultats de la première évaluation de la loi Évin dans les écoles, collèges et lycées (2002). Paris, OFDT, 2003, 168 p.","Rapport d étude");
index.dReg("200312196","docs/eftxmbjc.pdf","Recherche de l’alcoolémie dans les accidents corporels de la route et indicateurs d’alcoolisation. Tendances, 2003, (33), 1-4","Tendances");
index.dReg("200312195","docs/epfxcpja.pdf","CSST 1998-2001 : exploitation des rapports d'activité-type des Centres spécialisés de soins aux toxicomanes, 1998-2001. Paris, OFDT, 2003, 51 p.","Rapport d étude");
index.dReg("200312124","docs/eftambjc.pdf","Investigation of alcohol levels in road accidents with personal injury, and alcoholisation indicators. Tendances, 2003, (33), 6 p.","Tendances");
index.dReg("200311215","docs/eisxigjb.pdf","Note d'information du 14 novembre 2003 : Les produits collectés par le dispositif socio-sanitaire de juillet 2002 à septembre 2003. Paris, OFDT, 2003, 6 p.","Note d information");
index.dReg("200311208","docs/epfajajb.pdf","Phénomènes émergents liés aux drogues. Manuel européen sur la fonction d’information précoce sur les phénomènes émergents liés aux drogues. Paris, OFDT, 2003, 302 p.","Rapport d étude");
index.dReg("200310199","docs/epfxafja.pdf","Drogues, activité professionnelle et vie privée. Deuxième volet de l'étude qualitative sur les usagers intégrés en milieu professionnel. Paris, OFDT, 2003, 162 p.","Rapport d étude");
index.dReg("200310174","docs/epdxjaja.pdf","Résultats de l’enquête ESCAPAD 2002 : Usages de substances psychoactives chez les jeunes français de 17-19 ans. Paris, OFDT, 2003, 12 p.","Dossier de presse");
index.dReg("200310173","docs/epcxjaja.pdf","Usages de substances psychoactives chez les jeunes français de 17-19 ans. Paris, OFDT, 2003, 3 p.","Communiqué de presse");
index.dReg("2003099","docs/epfxflj9.pdf","Plan triennal 1999-2002 : Evaluation des programmes départementaux de prévention. Paris, OFDT, 2004, 132 p.","Rapport d étude");
index.dReg("2003098","docs/epfxjtj9.pdf","Plan triennal 1999-2002 : Evaluation du volet formation. Paris, OFDT, 2004, 116 p.","Rapport d étude");
index.dReg("2003097","docs/epfxcgj9.pdf","Plan triennal 1999-2002 : Evaluation des conventions départementales d'objectifs. Paris, OFDT, 2004, 156 p.","Rapport d étude");
index.dReg("200309197","docs/eftaigj9.pdf","Ecstasy and other synthetic drugs in France: situation portrayed by the SINTES information system, 1999-2002. Tendances, 2003, (32), 7 p.","Tendances");
index.dReg("200309172","docs/eftxigj9.pdf","Ecstasy et autres produits de synthèse en France. Etat des lieux issu du dispositif SINTES 1999-2002. Tendances, 2003, (32), 1-4","Tendances");
index.dReg("200309171","docs/epfxfbja.pdf","Drogues et adolescence : usages de drogues et contextes d'usage entre 17 et 19 ans, évolutions récentes ESCAPAD 2002. Paris, OFDT, 2003, 164 p., fig., tabl.","Rapport d étude");
index.dReg("20030917","docs/epfxmsj9.pdf","Evaluation du plan triennal de lutte contre la drogue et de prévention des dépendances (1999-2002). Rapport général. Paris, OFDT, 2003, 379 p.","Rapport d étude");
index.dReg("20030911","docs/epfxsfj9.pdf","Plan triennal 1999-2002 : Evaluation du programme de réduction des risques et de médiation sociale dans le 18ème arrondissement de Paris. Paris, OFDT, 2004, 110 p.","Rapport d étude");
index.dReg("20030910","docs/epfxadj9.pdf","Plan triennal 1999-2002 : Evaluation du rapprochement de structures spécialisées pour une prise en charge globale des addictions. Paris, OFDT, 2004, 92 p.","Rapport d étude");
index.dReg("200307214","docs/eisxigj7.pdf","Note d'information du 22 juillet 2003 : Première identification de 5-MeO-DMT (N,N-dimethyl-5-methoxy-tryptamine). Paris, OFDT, 2003, 3 p.","Note d information");
index.dReg("200307213","docs/eisxigj6.pdf","Note d'information du 7 juillet 2003 : AMT (alphamethyltryptanine). Paris, OFDT, 2003, 2 p.","Note d information");
index.dReg("200307200","docs/epcxjaj7.pdf","Tendances récentes et nouvelles drogues en France en 2002. Paris, OFDT, 2003, 3 p.","Communiqué de presse");
index.dReg("200307193","docs/eftapbj7.pdf","Recent trends and new drugs in France in 2002: results of the fourth national report. Tendances, 2003, (31), 1-6","Tendances");
index.dReg("200307162","docs/eftxpbj7.pdf","Tendances récentes et nouvelles drogues en France en 2002. Tendances, 2003, (31), 1-6","Tendances");
index.dReg("200307157","docs/epfxclj7.pdf","Grossesse et substitution : enquête sur les femmes enceintes substituées à la méthadone ou à la buprénorphine haut dosage et caractéristiques de leurs nouveau-nés. Paris, OFDT, 2003, fig., tabl.","Rapport d étude");
index.dReg("200306192","docs/eftafbj6.pdf","Adults and drugs: levels of use and recent trends. Tendances, 2003, (30), 1-6","Tendances");
index.dReg("200306161","docs/epfxxxj6.pdf","Substitution aux opiacés : synthèse des informations disponibles de 1996 à 2001 en France. Paris, OFDT, 2003, 80 p., tabl.","Rapport d étude");
index.dReg("200306158","docs/epfxpbj6.pdf","Phénomènes émergents liés aux drogues en 2002. Quatrième rapport national du dispositif TREND. Paris, OFDT, 2003, 287 p., tabl.","Rapport d étude");
index.dReg("200306154","docs/eftxfbj6.pdf","Les adultes et les drogues en France : niveaux d'usage et évolutions récentes. Tendances, 2003, (30), 1-6","Tendances");
index.dReg("200305191","docs/eftafbj5.pdf","Recent trends in drug use at the age of 17: ESCAPAD 2000-2002. Tendances, 2003, (29), 1-4","Tendances");
index.dReg("200305160","docs/epfxigj5.pdf","Regards sur l'ecstasy et d'autres produits de synthèse en France. Paris, OFDT, 2003, 213 p., fig., tabl.","Rapport d étude");
index.dReg("200305159","docs/epfxxxj5.zip","Observations locales des drogues : observations sur les usagers de drogues en 2002 dans douze sites de France. Rapports locaux du réseau des sites TREND. Paris, OFDT, 2003, 465 p., fig., tabl.","Rapport d étude");
index.dReg("200305153","docs/eftxfbj5.pdf","Evolutions récentes des usages de drogues à 17 ans : ESCAPAD 2000-2002. Tendances, 2003, (29), 1-4","Tendances");
index.dReg("200304151","docs/epbxdlj4.pdf","Evaluer l'intervention en toxicomanie : significations et conditions. Paris, OFDT, 2003, 80 p.","Rapport d étude");
index.dReg("200304150","docs/epbxhbj4.pdf","Dispositifs spécialisés alcool et toxicomanie, santé publique et nouvelle politique des addictions. Paris, OFDT, 2003, 128 p.","Rapport d étude");
index.dReg("200304149","docs/epbxcrj4.pdf","Les nouveaux usages de l'héroïne. Paris, OFDT, 2003, 117 p.","Rapport d étude");
index.dReg("200302225","docs/epcxjaj1.pdf","Le professeur Philippe-Jean Parquet devient président du conseil d'administration de l'Observatoire français des drogues et des toxicomanies. Paris, OFDT, 2003, 1 p.","Communiqué de presse");
index.dReg("200302198","docs/epcxjaj2.pdf","Les français et les drogues : quelles sont leurs opinions sur les politiques publique ? Comment perçoivent-ils les différents produits ? Résultats d'EROPP 2002 . Paris, OFDT, 2003, 3 p,","Communiqué de presse");
index.dReg("200302194","docs/epdxjaj2.pdf","Résultats de l’enquête EROPP 2002. Les Français et les drogues : quelles sont leurs opinions sur les politiques publiques ? Comment perçoivent-ils les différents produits ? Paris, OFDT, 2003, 13 p.","Dossier de presse");
index.dReg("200302145","docs/eisxslj2.pdf","Les consommations de produits psychoactifs à la fin de l'adolescence en PACA : exploitation régionale de l'enquête ESCAPAD 2000/2001. Paris, OFDT, 2003, 27 p.","Note d information");
index.dReg("200301190","docs/eftafbj1.pdf","Drugs and public policies: changes in perceptions and opinions, 1999-2002. Tendances, 2003, (28), 1-4","Tendances");
index.dReg("200301152","docs/eftxfbj1.pdf","Drogues et politiques publiques : évolution des perceptions et des opinions, 1999-2002. Tendances, 2003, (28), 1-4","Tendances");
index.dReg("200301132","docs/eprxfbj1.pdf","Penser les drogues : perceptions des produits et des politiques publiques. Enquête sur les représentations, opinions et perceptions sur les psychotropes, EROPP 2002. Paris, OFDT, 2003, 227 p.","Rapport d étude");
index.dReg("2002123189","docs/eftasaic.pdf","The use of psychoactive products in rock culture party environments. Tendances, 2002, (27), 1-4","Tendances");
index.dReg("2002123135","docs/eftxsaic.pdf","Les consommations de produits psychoactifs dans les milieux festifs de la culture rock. Tendances, 2002, (27), 1-4","Tendances");
index.dReg("2002122188","docs/eftatric.pdf","Significance, limitations and methods of internet research in the field of drugs and addiction. Tendances, 2002, (26), 1-6","Tendances");
index.dReg("2002122134","docs/eftxtric.pdf","Intérêts, limites et méthodes de recherche sur Internet dans le domaine des drogues et des addictions. Tendances, 2002, (26), 1-6","Tendances");
index.dReg("200212212","docs/eisxigic.pdf","Note d'information du 10 décembre 2002 (mise à jour de la note d'avril 2001) : Nouvelle identification de PMA. Paris, OFDT, 2002, 5 p.","Note d information");
index.dReg("200212136","docs/epbxsaic.pdf","Les consommations de produits psychoactifs dans les milieux festifs de la culture rock. Paris, OFDT, 2002, 116 p.","Rapport d étude");
index.dReg("2002121187","docs/eftaafic.pdf","Drug use and professional life: exploratory research. Tendances, 2002, (25), 1-4","Tendances");
index.dReg("2002121133","docs/eftxafic.pdf","Usages de drogues et vie professionnelle : recherche exploratoire. Tendances, 2002, (25), 1-4","Tendances");
index.dReg("200211211","docs/eisxigib.pdf","Note d'information du 20 novembre 2002 : Comprimé de MDEA dosé à 111 mg. Paris, OFDT, 2002, 4 p.","Note d information");
index.dReg("200210186","docs/eftadlia.pdf","Use of illicit drugs and social exclusion: state of knowledge in France. Tendances, 2002, (24), 1-4","Tendances");
index.dReg("200210129","docs/eftxdlia.pdf","Consommation de drogues illicites et exclusion sociale : état des connaissances en France. Tendances, 2002, (24), 1-4","Tendances");
index.dReg("200209121","docs/2ct2.pdf","Note d'information du 23 septembre 2002 : Identification de C-T-2. Paris, OFDT, 2002, 2 p.","Note d information");
index.dReg("200209120","docs/tma2.pdf","Note d'information du 3 septembre 2002 : Identification de TMA-2. Paris, OFDT, 2002, 2 p.","Note d information");
index.dReg("20020799","docs/anntrend.pdf","Annexes documentaires Trend 2001. Paris, OFDT, 2001, 161 p.","Rapport d étude");
index.dReg("200207229","docs/epdxjai7.pdf","Tendances récentes et nouvelles drogues en France en 2001 : phénomènes émergents liés aux usages de drogues. Paris, OFDT, 2002, 14 p.","Dossier de presse");
index.dReg("200207228","docs/epcxjai7.pdf","Tendances récentes et nouvelles drogues en France en 2001. Paris, OFDT, 2002, 3 p.","Communiqué de presse");
index.dReg("200207185","docs/eftapbi7.pdf","Emerging phenomena linked to the use of drugs in France in 2001. Tendances, 2002, (23), 1-4","Tendances");
index.dReg("200207137","docs/efixali7.pdf","Suisse : petits pas dans la lutte anti-blanchiment ; Paraguay-Brésil : narco-financement d'une base arrière d'Al-Qaida ; Afghanistan : forte croissance de la production d'opium dans les provinces du nord. Drogues Trafic International, 2002, (17), 1-5","Drogues, trafic international");
index.dReg("200207119","docs/bupro.pdf","Note d'information du 30 juillet 2002 (mise à jour de la note du 26/07/02) : Identification de Bupropion dans les échantillons de la base SINTES. Paris, OFDT, 2002, 2 p.","Note d information");
index.dReg("200207118","docs/salvia.pdf","Note d'information du 19 juillet 2002 : Première identification du principe actif de la Salvia Divinorum dan SINTES. Paris, OFDT, 2002, 3 p.","Note d information");
index.dReg("200207110","docs/raslab.pdf","Usages de drogues et vie professionnelle : recherche exploratoire. Paris, OFDT, 2002, 213 p.","Rapport d étude");
index.dReg("200207107","docs/tend23.pdf","Phénomènes émergents liés à l'usage de drogues en france en 2001. Tendances, 2002, (23), 1-4","Tendances");
index.dReg("200206184","docs/eftasli6.pdf","Drug use at the age of 18: principal results from the ESCAPAD 2001 survey. Tendances, 2002, (22), 1-4","Tendances");
index.dReg("200206131","docs/eprxfbi6.pdf","Santé, mode de vie et usages de drogues à 18 ans, ESCAPAD 2001. Paris, OFDT, 2002, 200 p.","Rapport d étude");
index.dReg("200206109","docs/eprxofi6.zip","Phénomènes émergents liés aux drogues en 2001 : rapports locaux des sites Trend. Paris, OFDT, 2002, 683 p.","Rapport d étude");
index.dReg("200206108","docs/cnamts.pdf","Substitution aux opiacés dans cinq sites de France en 1999 et 2000 : usagers et stratégies de traitement. Paris, OFDT, 2002, 84 p.","Rapport d étude");
index.dReg("200206106","docs/trend021.pdf","Phénomènes émergents liés aux drogues en 2001, rapport Trend. Paris, OFDT, 2002, 293 p.","Rapport d étude");
index.dReg("200206104","docs/tend22.pdf","Usages de drogues à 18 ans : principaux résultats de l'enquête ESCAPAD 2001. Tendances, 2002, (22), 1-4","Tendances");
index.dReg("200205232","docs/epcxjai5.pdf","Quels impacts d’une consommation de stupéfiants dans les accidents de la route ? Paris, OFDT, 2002, 2 p.","Communiqué de presse");
index.dReg("200205231","docs/epdxjai6.pdf","Tabac :  premier bilan sur l'application de la loi Evin en milieu scolaire. Paris, OFDT, 2002, 11 p.","Dossier de presse");
index.dReg("200205230","docs/epcxjai6.pdf","Tabac :  premier bilan sur l'application de la loi Evin en milieu scolaire. Paris, OFDT, 2002, 3 p.","Communiqué de presse");
index.dReg("200205210","docs/eisxigi5.pdf","Note d'information du 17 mai 2002 (mise à jour de la note du 04/04/02) : Identification de Methorphane dans des échantillons de la base SINTES. Paris, OFDT, 2002, 4 p.","Note d information");
index.dReg("200205183","docs/eftajci5.pdf","Implementation of the Evin law in schools: initial survey results. Tendances, 2002, (21), 1-4","Tendances");
index.dReg("200205169","docs/eisxppi5.pdf","Les consommations de produits psychoactifs à la fin de l'adolescence à la Réunion : exploitation locale de l'enquête ESCAPAD 2001. Paris, OFDT, 2002, 30 p., fig., tabl.","Note d information");
index.dReg("200205103","docs/tend21.pdf","L'application de la loi Evin en milieu scolaire : premiers résultats de l'enquête. Tendances, 2002, (21), 1-4","Tendances");
index.dReg("200205101","docs/dti16.pdf","Corée du Nord : les trafics n'ont pas d'odeur , Libye : la poutre et la paille. Drogues Trafic International, 2002, (16), 1-4","Drogues, trafic international");
index.dReg("20020497","docs/dti15.pdf","Etats-unis : hausse de la consommation d'héroïne et enjeux de la prévention , Pérou. Visite de Bush : la carotte et le bâton ; Autriche : réunion de la commission des stupéfiants. Drogues Trafic International, 2002, (15), 1-5","Drogues, trafic international");
index.dReg("200204209","docs/eisxigi4.pdf","Note d'information du 3 avril 2002 (mise à jour de la note de février 2002) : Identification de Tiletamine. Paris, OFDT, 2002, 3 p.","Note d information");
index.dReg("200204168","docs/eisxppi4.pdf","Les consommations de produits psychoactifs à la fin de l'adolescence en Guadeloupe : exploitation locale de l'enquête ESCAPAD 2001. Paris, OFDT, 2002, 30 p., fig., tabl.","Note d information");
index.dReg("200204164","docs/eisxfbi4.pdf","Les consommations de produits psychoactifs à la fin de l'adolescence dans l'Essonne : exploitation départementale de l'enquête ESCAPAD 2000/2001. Paris, OFDT, 2002, 26 p., fig.","Note d information");
index.dReg("200204125","docs/cemka.pdf","Evolution de la prise en charge des toxicomanes : enquête auprès des médecins généralistes en 2001 et comparaison 92-95-98-2001. Paris, OFDT, 2002, 87 p.","Rapport d étude");
index.dReg("200204105","docs/matos.pdf","Sous le signe du Matos : contextes, trajectoires, risques et sensations liés à l'injection de produits psychoactifs. Paris, OFDT, 2002, 200 p.","Rapport d étude");
index.dReg("20020395","docs/tend20.pdf","Evolution de la prise en charge des toxicomanes : enquête auprès des médecins généralistes en 2001 et comparaison 92-95-98-2001. Tendances, 2002, (20), 1-4","Tendances");
index.dReg("20020394","docs/dti14.pdf","Afghanistan : le défi de l'opium , République Dominicaine : plaque tournante du trafic et du blanchment ; Annexe : compte-rendu du rapport 2001 de l'OICS. Drogues Trafic International, 2002, (14), 1-9","Drogues, trafic international");
index.dReg("200203182","docs/eftaadi3.pdf","Trends in the care of drug addicts: survey among general practitioners in 2001 and comparison 92-95-98-2001. Tendances, 2002, (20), 1-4","Tendances");
index.dReg("200203167","docs/eisxppi3.pdf","Les consommations de produits psychoactifs à la fin de l'adolescence en Martinique : exploitation locale de l'enquête ESCAPAD 2001. Paris, OFDT, 2002, 22 p., fig., tabl.","Note d information");
index.dReg("200203146","docs/eisxfbj3.pdf","Les consommations de produits psychoactifs à la fin de l'adolescence en Bretagne : exploitation régionale de l'enquête ESCAPAD 2000/2001. Paris, OFDT, 2002, 29 p.","Note d information");
index.dReg("20020296","docs/dti13.pdf","Maroc : la production de cannabis dans le Rif. Drogues Trafic International, 2002, (13), 1-4","Drogues, trafic international");
index.dReg("200202202","docs/epbxali2.pdf","Rapport de mission (16 au 30 août 2001) sur la coopération française avec la Colombie dans le domaine des drogues. Paris, OFDT, 2002, 47 p.","Rapport d étude");
index.dReg("200202166","docs/eisxppi2.pdf","Les consommations de produits psychoactifs à la fin de l'adolescence en Seine-Saint-Denis : exploitation dépatementale de l'enquête ESCAPAD 2000/2001. Paris, OFDT, 2002, 4 p.","Note d information");
index.dReg("200202156","docs/eisxfbi2.pdf","Les consommations de produits psychoactifs à la fin de l'adolescence en Nord-Pas de Calais : exploitation régionale de l'enquête ESCAPAD 2000/2001. Paris, OFDT, 2002, 18 p., fig., graph., tabl.","Note d information");
index.dReg("200202117","docs/2cb.pdf","Note d'information du 19 février 2002 (version initiale d'octobre 2001) :Premières identifications en 2001/2002 de 2C-B (4-Bromo-2,5-Dimethoxyphenethylamine) dans la base SINTES. Paris, OFDT, 2002, 5 p.","Note d information");
index.dReg("200202102","docs/espad992.pdf","Alcool, tabac, cannabis et autres drogues illicites parmi les élèves de collège et de lycée. ESPAD 99 France. (Tome 1). Paris, OFDT, 2002, 148 p.","Rapport d étude");
index.dReg("200202100","docs/espad991.pdf","Alcool, tabac, cannabis et autres drogues illicites parmi les élèves de collège et de lycée. ESPAD 99 France. (Tome 2). Paris, OFDT, 2002, 225 p.","Rapport d étude");
index.dReg("20020192","docs/dd2002.pdf","Drogues et dépendances : indicateurs et tendances 2002. Paris, OFDT, 2002, 368 p.","indicateurs et tendances");
index.dReg("20020189","docs/tend19.pdf","Drogues et dépendances : indicateurs et tendances 2002. Tendances, 2002, (19), 1-4","Tendances");
index.dReg("20020187","docs/dti12.pdf","Colombie : les cultures de coca font de la résistance , Colombie/Pérou : le retour des opiacés. Drogues Trafic International, 2002, (12), 1-5","Drogues, trafic international");
index.dReg("20020165","docs/dt2002d.pdf","Drogues et dépendances , Indicateurs et tendances (Annexes)","Indicateurs et tendances");
index.dReg("20020164","docs/dt2002c.pdf","Drogues et dépendances, Indicateurs et tendances (Cadre légal)","Indicateurs et tendances");
index.dReg("20020163","docs/dt2002b.pdf","Drogues et dépendances, Indicateurs et tendances (Approche par produits)","Indicateurs et tendances");
index.dReg("20020162","docs/dt2002a.pdf","Drogues et dépendances, Indicateurs et tendances (Approche transversale)","Indicateurs et tendances");
index.dReg("20020161","docs/dt2002.pdf","Drogues et dépendances, Indicateurs et tendances (Rapport complet)","Indicateurs et tendances");
index.dReg("200201234","docs/epdxjai1.pdf","Drogues et dépendances 2002 : indicateurs et tendances. Paris, OFDT, 2002, 12 p.","Dossier de presse");
index.dReg("200201233","docs/epcxjai1.pdf","Drogues et dépendances 2002 : indicateurs et tendances. Paris, OFDT, 2002, 1 p.","Communiqué de presse");
index.dReg("200201181","docs/eftajci1.pdf","Drugs and dependence: indicators and trends in 2002. Tendances, 2002, (19), 1-4","Tendances");
index.dReg("200201170","docs/eisxsli1.pdf","Les consommations de produits psychoactifs à la fin de l'adolescence en Champagne-Ardenne : exploitation régionale de l'enquête ESCAPAD 2000/2001. Paris, OFDT, 2002, 27 p., fig.","Note d information");
index.dReg("200201165","docs/eisxppi1.pdf","Les consommations de produits psychoactifs à la fin de l'adolescence en Languedoc-Roussillon : exploitation régionale de l'enquête ESCAPAD 2000/2001. Paris, OFDT, 2002, 30 p., fig., tabl.","Note d information");
index.dReg("200201155","docs/eisxfbi1.pdf","Les consommations de produits psychoactifs à la fin de l'adolescence en Limousin : exploitation régionale de l'enquête ESCAPAD 2000/2001. Paris, OFDT, 2002, 18 p., graph., tabl.","Note d information");
index.dReg("200201116","docs/vi0102.pdf","Veille Internet sur les substances psychoactives dans le cadre du projet TREND: 2C-B (Janvier 2002) Paris, OFDT, 2002, 9 p","Veille Internet");
index.dReg("20020","docs/eisxfbi3.pdf","Les consommations de produits psychoactifs à la fin de l'adolescence en Bretagne : exploitation régionale de l'enquête ESCAPAD 2000/2001. Paris, OFDT, 2002, 29 p., fig.","Note d'information");
index.dReg("20011293","docs/subutex.pdf","Usagers de drogues injectables et buprénorphine haut dosage : analyse des déviations de son utilisation. Paris, OFDT, 2001, 75 p.","Rapport d étude");
index.dReg("20011290","docs/tend18.pdf","Tensions et transformations des pratiques de substitution en ville, suivi de: Psychotropes et dépendances : profils et trajectoires des consommations de psychotropes. Tendances, 2001, (18), 1-4","Tendances");
index.dReg("20011288","docs/dti11.pdf","Afghanistan : impact sur la toxicomanie en France de la reprise de la production d'opium en 2002 , Pologne : l'exemple du centre MONAR de Cracovie ; République démocratique du Congo (RDC) : les ONG victimes de persécutions,  2001, (11), 1-5","Drogues, trafic international");
index.dReg("200112203","docs/epbxalhc.pdf","Rapport sur la situation du cannabis dans le rif marocain (juin-août 2001). Paris, OFDT, 2001, 23 p.","Rapport d étude");
index.dReg("200112180","docs/eftambhc.pdf","Monitoring drug-using patients in general medicine: qualitative approach; Psychotropic drugs and dependence: user's profiles and behaviour patterns. Tendances, 2001, (18), 1-4","Tendances");
index.dReg("20011191","docs/tend17.pdf","Drogues illicites et délinquance : regards sur les travaux nord-américains. Tendances, 2001, (17), 1-4","Tendances");
index.dReg("20011174","docs/dti10.pdf","Spécial Pologne. Drogues Trafic International, 2001, (10), 1-4","Drogues, trafic international");
index.dReg("200111179","docs/eftasbhb.pdf","Illicit drugs and delinquency: an examination of the North American work. Tendances, 2001, (17), 1-4","Tendances");
index.dReg("20011073","docs/dti09.pdf","Monde : le trafic des drogues après le 11 septembre , Bangladesh : géopolitique régionale et toxicomanie. Drogues Trafic International, 2001, (09), 1-4","Drogues, trafic international");
index.dReg("20010972","docs/dti08.pdf","Bénin : un petit pays face aux grands trafics , Colombie : des contrôles portuaires dissuasifs. Drogues Trafic International, 2001, (08), 1-4","Drogues, trafic international");
index.dReg("200109227","docs/epdxjai9.pdf","Résultats de l’enquête ESCAPAD 2001. Quels sont les usages de substances psychoactives chez les jeunes de 18 ans en France ? Paris, OFDT, 2001, 13 p.","Dossier de presse");
index.dReg("200109226","docs/epcxjai9.pdf","Quels sont les usages de substances psychoactives chez les jeunes de 18 ans en France ? Paris, OFDT, 2001, 3 p.","Communiqué de presse");
index.dReg("200109178","docs/eftafbh9.pdf","Alcohol, tobacco and psychotropic drugs in seniors: the use of legal psychoactive substances between the ages of 60 and 75. Tendances, 2001, (16), 1-4","Tendances");
index.dReg("200109111","docs/vi0801.pdf","Veille Internet sur les substances psychoactives dans le cadre du projet TREND : Yaba , Pémoline (Septembre 2001). Paris, OFDT, 2001, 13 p.","Veille Internet");
index.dReg("2001091","docs/tend16.pdf","Alcool, tabac et médicaments psychotropes chez les seniors : les usages de substances psychoactives licites entre 60 et 75 ans. Tendances, 2001, (16), 1-4","Tendances");
index.dReg("20010898","docs/matern.pdf","Maternité, interaction mère-enfant et toxicomanie. Paris, OFDT, 2001, 112 p.","Rapport d étude");
index.dReg("20010871","docs/dti07.pdf","Slovaquie : une cible du trafic d'héroïne , Congo (Brazzaville) : le cannabis contre la paix. Drogues Trafic International, 2001, (07), 1-4","Drogues, trafic international");
index.dReg("200108112","docs/vi901.pdf","Veille Internet sur les substances psychoactives dans le cadre du projet TREND : Cathinone (Khat, methcathinone) , Ephédrine ; MBDB  (Août 2001) Paris, OFDT, 2001, 21 p.","Veille Internet");
index.dReg("2001075","docs/tend15.pdf","Phénomènes émergents liés à l'usage de drogues. Tendances, 2001, (15), 1-4","Tendances");
index.dReg("2001072","docs/fat.pdf","Evaluation du dispositif familles d'accueil pour toxicomanes. Paris, OFDT, 2001, 170 p.","Rapport d étude");
index.dReg("200107177","docs/eftapbh7.pdf","Emerging phenomena linked to drug use. Tendances, 2001, (15), 1-4","Tendances");
index.dReg("200107130","docs/dti06.pdf","Canada : une narco-criminalité aux multiples facettes ; Vietnam : la  pilule qui secoue. Drogues Trafic International, 2001, (06), 1-4","Drogues, trafic international");
index.dReg("20010670","docs/dti05.pdf","Colombie : conflit de la drogue ou conflit politique ? , Serbie-Kosovo : l'héroïne du conflit. Drogues Trafic International, 2001, (05), 1-4","Drogues, trafic international");
index.dReg("2001064","docs/tend14.pdf","Approche sociologique des trafics de drogues : carrières et processus pénal. Tendances, 2001, (14), 1-4","Tendances");
index.dReg("2001063","docs/trend2001.pdf","Tendances récentes, rapport TREND. Paris, OFDT, 2001, 167 p.","Rapport d étude");
index.dReg("200106176","docs/eftaddh6.pdf","Sociological approach to drug trafficking: career paths and penal process. Tendances, 2001, (14), 1-4","Tendances");
index.dReg("2001057","docs/carrieres.pdf","Carrières, territoires et filières pénales : pour une sociologie comparée des trafics de drogue. Paris, OFDT, 2001, 361 p.","Rapport d étude");
index.dReg("20010569","docs/dti04.pdf","Iran : ligne de défense avancée pour l'Europe , République Tchèque : du tout répressif au tout prévention. Drogues Trafic International, 2001, (04), 1-4","Drogues, trafic international");
index.dReg("2001056","docs/psydependance.pdf","Psychotropes et dépendances : profils des consommateurs et trajectoires de leurs comportements. Paris, OFDT, 2001, 95 p.","Rapport d étude");
index.dReg("20010554","docs/carrieres.zip","Carrières, territoires et filières pénales : pour une sociologie comparée des trafics de drogue (Hauts-de-Seine, Nord, Seine-Saint-Denis). Paris, OFDT, 2001, 361 p.","Rapport d étude");
index.dReg("200105113","docs/vi0501.pdf","Veille Internet sur les substances psychoactives dans le cadre du projet TREND: 2C-T-2 et 2C-T-7 (Mai 2001) Paris, OFDT, 2001, 11 p.","Veille Internet");
index.dReg("2001049","docs/tend13.pdf","Pratiques sportives et usage de produits psychoactifs, de l'adolescence à l'âge adulte. Tendances, 2001, (13), 1-4","Tendances");
index.dReg("2001048","docs/toxicomanies.pdf","Toxicomanie, police, justice : trajectoires pénales. Paris, OFDT, 2001, 192 p.","Rapport d étude");
index.dReg("20010468","docs/dti03.pdf","Ukraine : du trafic de transit à la toxicomanie de masse , Roumanie : des livraisons mal contrôlées. Drogues Trafic International, 2001, (03), 1-4","Drogues, trafic international");
index.dReg("200104175","docs/eftafbh4.pdf","Participation in sport and use of psychoactive products from adolescence to adulthood. Tendances, 2001, (13), 1-4","Tendances");
index.dReg("200104115","docs/vi0500.pdf","Veille Internet sur les substances psychoactives dans le cadre du projet TREND: 4-MTA (Avril-Mai 2000) Paris, OFDT, 2000, 3 p.","Veille Internet");
index.dReg("20010411","docs/aresquali.pdf","Suivi de patients usagers de drogues en médecine générale : tensions et transformations des pratiques de substitution en ville, approche qualitative. Paris, OFDT, 2001, 154 p.","Rapport d étude");
index.dReg("20010410","docs/aresquanti.pdf","Suivi de patients usagers de drogues en médecine générale : étude prospective de suivi de 95 patients, approche quantitative. Paris, OFDT, 2001, 89 p.","Rapport d étude");
index.dReg("20010386","docs/tend12gb.pdf","Review on the contribution to evaluating the policy for health risk reduction in intravenous drug users. Tendances, 2001, (12), 1-8","Tendances");
index.dReg("20010367","docs/dti02.pdf","Suède : infléchissement de la politique antidrogue ? , Europe : la presse et la situation internationale des drogues ; Trinité-et-Tobago : la guerre des cartels. Drogues Trafic International, 2001, (02), 1-4","Drogues, trafic international");
index.dReg("20010314","docs/ups.pdf","Evaluation des unités pour sortants (UPS). Marseille, ORS PACA, 2001, 117 p.","Rapport d étude");
index.dReg("20010312","docs/tend12.pdf","Contribution à l'évaluation de la politique de réduction des risques sanitaires chez les usagers de drogues intraveineux. Tendances, 2001, (12), 1-4","Tendances");
index.dReg("20010266","docs/dti01.pdf","Russie : héroïne, sécurité nationale et politique en Asie centrale , République démocratique du Congo : des drogues dures sous haute protection. Drogues Trafic International, 2001, (01), 1-4","Drogues, trafic international");
index.dReg("20010257","docs/capture.zip","Estimations locales de la prévalence de l'usage d'opiacés et cocaïne en France : une étude multicentrique à Lens, Lille, Marseille, Nice et Toulouse. Paris, OFDT, 2001, 112 p.","Rapport d étude");
index.dReg("20010256","docs/liress.zip","Pratiques et représentations émergentes dans le champ de l'usage de drogues en France. Paris, OFDT, 2001, 272 p.","Rapport d étude");
index.dReg("20010216","docs/capture.pdf","Estimations locales de la prévalence de l'usage d'opiacés et cocaïne en France : une étude multicentrique à Lens, Lille, Marseille, Nice et Toulouse. Paris, OFDT, 2001, 112 p.","Rapport d étude");
index.dReg("20010215","docs/liress.pdf","Pratiques et représentations émergentes dans le champ de l'usage de drogues en France. Paris, OFDT, 2001, 272 p.","Rapport d étude");
index.dReg("200102114","docs/vi0201.pdf","Veille Internet sur les substances psychoactives dans le cadre du projet TREND : PMA , PMMA ; DXM (Février 2001) Paris, OFDT, 2001, 15 p.","Veille Internet");
index.dReg("20010185","docs/tend11gb.pdf","Coffee-shops in the Netherlands: the Dutch tolerance in practice. Tendances, 2001, (11), 1-9","Tendances");
index.dReg("20010143","docs/tend11.pdf","Les coffee-shop aux Pays-bas : la tolérance à la néerlandaise. Tendances, 2001, (11), 1-4","Tendances");
index.dReg("20001284","docs/tend10gb.pdf","The use of psychoactive substances among adolescents in their late teens: setting up an annual survey. Tendances, 2000, (10), 1-11","Tendances");
index.dReg("20001244","docs/tend10.pdf","Les usages de substances psychoactives à la fin de l'adolescence : mise en place d'une enquête annuelle. Tendances, 2000, (10), 1-4","Tendances");
index.dReg("20001233","docs/paysbas.pdf","Politiques et expérimentations sur les drogues aux Pays-Bas. Paris, OFDT, 2000, 155 p.","Rapport d étude");
index.dReg("20001218","docs/escapad00.pdf","Regards sur la fin de l'adolescence : consommations de produits psychoactifs dans l'enquête ESCAPAD 2000. Paris, OFDT, 2000, 220 p.","Rapport d étude");
index.dReg("20001217","docs/bus.pdf","Evaluation du dispositif Bus méthadone. Paris, OFDT, 2000, 142 p.","Rapport d étude");
index.dReg("20001183","docs/tend9gb.pdf","Alcohol and criminality. Tendances, 2000, (9), 1-10","Tendances");
index.dReg("20001145","docs/tend9.pdf","Alcool et délinquance. Tendances, 2000, (9), 1-4","Tendances");
index.dReg("20001038","docs/pe.pdf","Evaluation des Points écoute jeunes et/ou parents créés à partir de la Circulaire n° 97/280 du 10 avril 1994. Paris, OFDT, 2000, 262 p.","Rapport d étude");
index.dReg("20000939","docs/cout2000.pdf","Le coût social des drogues licites (alcool et tabac) et illicites en France. Paris, OFDT, 2000, 277 p.","Rapport d étude");
index.dReg("20000858","docs/it.zip","L'injonction thérapeutique : évaluation du dispositif légal de prise en charge sanitaire des usagers de drogues interpellés. Paris, OFDT, 2000, 159 p.","Rapport d étude");
index.dReg("20000840","docs/it.pdf","L'injonction thérapeutique : évaluation du dispositif légal de prise en charge sanitaire des usagers de drogues interpellés. Paris, OFDT, 2000, 159 p.","Rapport d étude");
index.dReg("20000682","docs/tend8gb.pdf","How do the French perceive heroin users ?. Tendances, 2000, (8), 1-12","Tendances");
index.dReg("20000646","docs/tend8.pdf","Comment les Français se représentent-ils les usagers d'héroïne ?. Tendances, 2000, (8), 1-4","Tendances");
index.dReg("20000459","docs/activite00.pdf","Rapport d'activité 2000","Rapport d activité");
index.dReg("20000441","docs/eropp99.pdf","EROPP 99 : enquête sur les représentations, opinions et perceptions relatives aux psychotropes. Paris, OFDT, 2000, 203 p.","Rapport d étude");
index.dReg("20000381","docs/tend7gb.pdf","Recent trends relating to psychoactive substances use and synthetic substances components. Tendances, 2000, (7), 1-7","Tendances");
index.dReg("20000355","docs/trend2000.zip","Tendances récentes, rapport TREND. Paris, OFDT, 2000, 99 p.","Rapport d étude");
index.dReg("20000347","docs/tend7.pdf","Tendances récentes sur les consommations de produits psychoactifs et la composition des substances de synthèse. Tendances, 2000, (7), 1-4","Tendances");
index.dReg("20000342","docs/cesdip.pdf","Le consommateur de produits illicites et l'enquête de police judiciaire : étude exploratoire à partir des procédures de police judiciaire. Paris, OFDT, 2000, 55 p.","Rapport d étude");
index.dReg("20000313","docs/trend2000.pdf","Tendances récentes, rapport TREND. Paris, OFDT, 2000, 99 p.","Rapport d étude");
index.dReg("20000280","docs/tend6gb.pdf","Psychoactive substances used by the 14-18 year-olds attending school: 1999 ESPAD survey, 1993-99 evolution. Tendances, 2000, (6), 1-8","Tendances");
index.dReg("20000248","docs/tend6.pdf","Consommations de substances psychoactives chez les 14-18 ans scolarisés : premiers résultats de l'enquête ESPAD 1999 - évolution 1993-1999. Tendances, 2000, (6), 1-6","Tendances");
index.dReg("19991236","docs/dt99.pdf","Drogues et toxicomanies: indicateurs et tendances, 1999. Paris, OFDT, 1999, 271 p.","indicateurs et tendances");
index.dReg("19991229","docs/pes.pdf","Caractéristiques sociales, consommations et risques chez les usagers de drogue fréquentant les programmes d'échange de seringues en France. Paris, OFDT, 1999, 62 p.","Rapport d étude");
index.dReg("199912279","docs/tend5gb.pdf","Distribution of intravenous injection in France. Tendances, 1999, (5), 1-9","Tendances");
index.dReg("199912249","docs/tend5.pdf","La diffusion de l'injection intraveineuse de l'héroïne en France. Tendances, 1999, (5), 1-4","Tendances");
index.dReg("199912178","docs/tend4gb.pdf","Drugs and drug addiction, perceptions and opinions in 1999: first results. Tendances, 1999, (4), 1-8","Tendances");
index.dReg("199912150","docs/tend4.pdf","Drogues et toxicomanie, l'état des perceptions et opinions en 1999 : premiers résultats. Tendances, 1999, (4), 1-4","Tendances");
index.dReg("19991177","docs/tend3gb.pdf","Synthetic drugs in Europe: a standardized and widespread phenomenon. Tendances, 1999, (3), 1-7","Tendances");
index.dReg("19991151","docs/tend3.pdf","Les drogues synthétiques en Europe : uniformisation et généralisation du phénomène. Tendances, 1999, (3), 1-4","Tendances");
index.dReg("19991132","docs/aleas.pdf","Alcool, cannabis, ecstasy chez les 18-25 ans en Centre Bretagne. Enquête exploratoire. Paris, OFDT, 1999, 40 p.","Rapport d étude");
index.dReg("19991031","docs/filieres.pdf","Les filières produits psychotropes à partir des soirées de musique techno. Paris, OFDT, 1999, 196 p.","Rapport d étude");
index.dReg("19991030","docs/ecsta.pdf","Ecsta, Trip, Coke et Speed. Approche ethnographique de la consommation d'ecstasy et ses dérivés, les Méthylènedioxyamphétamines, ainsi que des autres drogues licites et illicites associées. Paris, OFDT, 1999, 123 p.","Rapport d étude");
index.dReg("19990976","docs/tend2gb.pdf","Drug use and public policies: indicators and trends in 1999. Tendances, 1999, (2), 1-7","Tendances");
index.dReg("19990920","docs/tend2.pdf","Usages de drogues et dispositifs publics : indicateurs et tendances en 1999. Tendances, 1999, (2), 1-4","Tendances");
index.dReg("19990519","docs/tend1.pdf","Les Français et les drogues : perceptions, opinions et attitudes 1988-1998. Tendances, 1999, (1), 1-4","Tendances");
index.dReg("19990460","docs/activite99.pdf","Rapport d'activité 1999","Rapport d activité");
index.dReg("19990437","docs/lyceenscadis.pdf","Les conduites déviantes des lycéens. Paris, OFDT, 1999, 243 p.","Rapport d étude");
index.dReg("19990427","docs/zep.pdf","Les conduites déviantes des lycéens dans les établissements classés en ZEP et dans les autres. Paris, OFDT, 1999, 45 p.","Rapport d étude");
index.dReg("19990426","docs/lyceens.pdf","Les lycéens parisiens et les substances psychoactives : évolutions. Paris, OFDT, 1999, 169 p.","Rapport d étude");
index.dReg("19990325","docs/vm.pdf","Héroïne et cocaïne de Barcelone à Perpignan : des économies souterraines ethniques de survie à la généralisation des trafics transfrontaliers de proximité. Paris, OFDT, 1999, 52 p.","Rapport d étude");
index.dReg("19990124","docs/milieuscolaire.pdf","Evaluation en milieu scolaire d'un programme de prévention primaire en matière de toxicomanie. Paris, OFDT, 1999, 109 p.","Rapport d étude");
index.dReg("199901201","docs/epaxjcf1.pdf","Drugs and drug addiction: indicators and trends, 1999. Paris, OFDT, 1999, 271 p.","Indicateurs et tendances");
index.dReg("19981134","docs/eval.pdf","Evolution de la prise en charge des toxicomanes. Enquête auprès des médecins généralistes en 1998 et comparaison 92-95-98. Paris, OFDT, 1998, 49 p.","Rapport d étude");
index.dReg("199811204","docs/epbxfbe9.pdf","Perceptions, opinions, attitudes et connaissances de la population française en matière de toxicomanie. Etats des lieux et étude des évolutions depuis la fin des années 80. Paris, OFDT, 1998, 62 p.","Rapport d étude");
index.dReg("19980723","docs/fnails2.pdf","Etude du fichier FNAILS des interpellations pour usage de stupéfiants au niveau de l'individu. Paris, OFDT, 1998, 59 p.","Rapport d étude");
index.dReg("19980575","docs/tend1gb.pdf","The French and the drugs: perceptions, opinions and attitudes 1988-1998. Tendances, 1999, (1), 1-7","Tendances");
index.dReg("19980552","docs/ces.pdf","Les comités d'environnement social. Paris, OFDT, 1998, 117 p.","Rapport d étude");
index.dReg("19980522","docs/kopp.pdf","Vers l'analyse du coût des drogues illégales. Un essai de mesure du coût de la politique publique de la drogue et quelques réflexions sur la mesure des autres coûts. Paris, OFDT, 1998, 80 p","Rapport d étude");
index.dReg("199804128","docs/activ98.pdf","Rapport d'activité 1998","Rapport d activité");
index.dReg("19980353","docs/orsmip.pdf","Estimations locales de la prévalence de la toxicomanie : rapport final. Paris, OFDT, 1998, 104 p.","Rapport d étude");
index.dReg("19980228","docs/gironde.pdf","Recherche sur les usages d'ecstasy en Gironde. Paris, OFDT, 1998, 44 p.","Rapport d étude");
index.dReg("19971135","docs/ecstapilote.pdf","L'ecstasy : recherche pilote. Paris, OFDT, 1997, 116 p.","Rapport d étude");
index.dReg("19970721","docs/first.pdf","Familles et toxicomanies. Initiatives privées et publiques : groupes parents, service d'aide téléphonique, de nouveaux espaces pour la parole. Paris, OFDT, 1997, 202 p","Rapport d étude");
index.dReg("199704127","docs/activ97.pdf","Rapport d'activité 1997","Rapport d activité");
index.dReg("199604126","docs/activ96.pdf","Rapport d'activité 1996","Rapport d activité");
